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Recent reports focus on children 
and young people in Ireland
See page 8–14
EU National Drug Co-ordinators 
meet in Dublin
Alex White TD, Minister of State at the Department of Health, hosted a meeting of the EU 
National Drug Co-ordinators in Dublin Castle on 8–9 April 2013 as part of the Irish Presidency 
of the Council of the European Union. The meeting brought together drug policy formulators 
from member states and EU institutions. 
While referring to the complexities and difficulties of the drug phenomenon, which he said 
is truly global in nature, Minister White also spoke of the problems being experienced by 
individuals, families and communities on the ground. He spoke of his responsibility for the 
implementation of the Irish National Drugs Strategy (NDS), and the structures established to 
maximise the chances of the 63 actions of the NDS being implemented. He also told delegates: 
At EU level we must address the challenge of ensuring that there is a focus on the 
implementation of agreed Actions, particularly through the Horizontal Working Party on 
Drugs, but also through robust links with other EU bodies and through meetings of the EU 
National Drug Co-ordinators. On the international level he added: If we as the EU can speak 
with one strong voice at international fora we can really make an impact on the overall 
global drugs situation.
Speakers at the EU National Drug Co-ordinators meeting:
Front row: l to r, Dr Austin O’Carroll, general practitioner; Detective Sergeant Brian Roberts; 
Michael Conroy, Drug Policy Unit DOH; Minister Alex White TD; Dr Suzi Lyons, HRB; Professor 
Catherine Comiskey, NACDA chair.
Middle row: l to r, Ms Geraldine Hartnett, manager of family services Aislinn; Dr Denis O’Driscoll, 
chief pharmacist HSE Addiction Services; Ms Megan O’Leary, development worker Family Support 
Network; Mr Fergal Black, director of health care Irish Prison Services; Mr Tony Geoghegan, CEO 
Merchants Quay Ireland.
Back row: l to r, Mr Joe Doyle, national planning specialist, HSE Social Inclusion; Ms Brid Walsh, 
national rehabilitation co-ordinator, HSE; Mr Tony Duffin, director Ana Liffey Drug Poject; Mr Ger 
Twohig, project worker RADE; Mr Joe Kirby, rehabilitation co-ordinator, HSE Cork/Kerry.
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The theme of the two-day meeting was ‘From 
Use to Recovery: Experiences and Future 
Approaches in Drug Policy’. Speakers from 
Ireland’s statutory, community and voluntary 
sectors addressed the meeting on a range of 
topics including drug prevalence in Ireland, drug 
treatment provision, recovery and rehabilitation, 
as well as legislation to tackle drugs supply in 
Ireland – all with a focus on policy issues. 
Delegates from across EU member states and 
the EU institutions also provided contributions 
and responses covering aspects of drugs policy 
across the EU. The meeting concluded with a 
presentation on the drugs situation in Croatia, 
with the accession of that country to EU 
membership due to take place in July 2013.
As part of the effort to ensure the relevance and 
timeliness of the national drug co-ordinators 
conference, the Irish Presidency took the 
innovative step of choosing recovery as the 
theme of the conference as it is a key policy area 
of the forthcoming EU Action Plan on Drugs. 
The Irish Presidency made a presentation on the 
outcomes of the conference to a subsequent 
meeting of the Horizontal Working Party on 
Drugs (HDG), highlighting four issues that 
featured prominently in discussions during the 
two-day conference:
 ■ access to treatment for marginalised groups;
 ■ the benefits of interagency working;
 ■ the need to address the holistic needs of 
people; and
 ■ the challenges and possible responses 
in developing drugs policy in a time of 
recession.
The HDG will be encouraged to focus further on 
these issues and to continuously monitor and 
review progress on the implementation of the 
Action Plan when it is finalised.
Ireland’s 7th EU Presidency  
and drug policy1
Ireland has earned a reputation for energetically 
pursuing drug policy issues when holding the 
Presidency of the Council of the European 
Union. For example, the first joint European 
action on drugs was adopted in December 
1996 when Ireland held the Presidency.2 In 
2004, during its next tenure of the Presidency, 
Ireland kicked off the development of the EU 
Drugs Strategy 2005–2012 with a major EU 
drugs conference in Dublin.3 During the first 
six months of this year, Ireland has presented a 
draft EU Action Plan on Drugs 2013–2016 to the 
other 26 member states and the EU institutions. 
Since then Ireland has worked steadily as 
‘neutral arbiter’ to win agreement on its 
contents.4 It is anticipated that all outstanding 
issues will have been resolved by the time of the 
June meeting of the Council of Justice and Home 
Affairs Ministers and that the Council will adopt 
the Plan. 
Leading on EU drug policy gives Irish policy 
makers unique first-hand experience of the 
international dimensions of the drug problem. 
They gain a deepened awareness of the similar 
challenges faced by different countries, the 
interconnectedness of the issues not only 
between different countries around the globe 
but also between the global, EU, national and 
local levels. So observes Michael Conroy, head 
of the Drug Policy Unit in the Department 
of Health, who has also headed the Irish 
Presidency Steering Group on Drugs Issues, 
which comprises a small number of officials 
drawn from his own department and from 
the departments of Foreign Affairs and Trade, 
and Justice and Equality. Set up in early 2012, 
this steering group has itself been drawn from 
the larger International Drug Issues Group 
(IDIG), which meets every quarter to co-
ordinate Ireland’s drug policy responses on the 
international stage.5 Members of the larger 
group, including representatives of An Garda 
Síochána, Revenue’s Customs Service and the 
Irish Medicines Board, have also contributed to 
the work of the steering group when requested.
EU policy
Work on drugs policy at EU level proceeds via 
the Horizontal Working Party on Drugs (HDG), 
a working party of the European Council, 
comprising representatives from each of the 
27 member states and based in Brussels.6 The 
Presidency chairs the monthly meetings of 
the HDG, organises presentations and seeks 
decisions. Professor Des Corrigan, formerly chair 
of Ireland’s National Advisory Committee on 
Drugs, has chaired the HDG during Ireland’s 
Presidency. 
As well as focusing on the EU Action Plan 
on Drugs, the Irish Presidency has sought to 
advance a proposal for EU-wide legislation on 
new psychoactive substances. At this stage 
many member states have gone further than 
the EU in progressing legislation controlling 
new psychoactive substances at national 
level. For example, under the Misuse of Drugs 
Acts, Ireland has banned approximately 260 
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3substances and a further 40 are in the pipeline, and the 
Criminal Justice (Psychoactive Substances) Act 2010 has led 
to the closure of most headshops in Ireland. By contrast, 
under current EU legislation only three new psychoactive 
substances have been banned across all 27 member states 
and a further two are in the pipeline. Thus, there is not 
a uniform approach to the control of new psychoactive 
substances across the member states and it is not possible 
to effectively control the availability of these substances 
within the EU. The proposal is expected to revise the 2005 
EU legislation,7 and to speed up the process for bringing 
new substances under control. At the time of going to press, 
the proposals were still being finalised by the European 
Commission.8
The Presidency also organises meetings of various EU 
expert and NGO groups. In April the EU’s national drug 
co-ordinators met in Dublin for their regular six-monthly 
meeting (see separate article on this meeting). In February 
representatives of the EU’s Civil Society Forum on Drugs 
(CSF) met with the HDG to give their views on the draft 
EU Action Plan on Drugs. The member organisations of 
the CSF are appointed for two-year periods, and in June 
2013 the members of the newly appointed CSF, including 
representatives from Merchants Quay Ireland and CityWide 
Drugs Crisis Campaign, will meet in plenary session with the 
HDG. This further engagement under the Irish Presidency 
will be the first ever such meeting between the entire 
membership of both bodies.9
International policy
Beyond its borders, the EU plays an influential role in drug 
policy at international level, and Ireland has been to the 
forefront of this work for the first half of 2013. At the 56th 
Session of the Commission on Narcotic Drugs (CND), the 
UN’s drug-policy-making body, which brings together 
representatives from all over the world to debate drugs 
policy and its implementation, Minister of State Alex White 
TD delivered the opening EU Statement at the first Plenary 
Session. The Minister commented: ‘This is a vitally important 
conference providing an opportunity to debate policies 
and strategies to combat the drugs problem worldwide. I 
had an opportunity to hear the views and experiences of 
countries from every region of the world. As we address 
the enormous challenges associated with drugs misuse in 
Ireland, we must also continue our work in the international 
context, particularly through the Irish Presidency of the 
European Council.’ Ireland with the European External 
Action Service (EEAS) co-ordinated the European input to 
the CND, including five resolutions sponsored by the EU 
(see separate article in this issue on the 56th Session of the 
CND). In a hectic schedule, Minister White also availed of 
the opportunity at the CND to hold bilateral meetings with 
New Zealand and Ecuador.
The EU is also engaged in dialogues on the drugs problem 
with regions and individual countries around the world. 
In conjunction with the EEAS, Ireland has led the EU 
representation in meetings with the Community of Latin 
American and Caribbean States (CELAC), the Western 
Balkans, and the United States. 
CELAC: Ireland is leading EU efforts to agree a joint 
Declaration on drugs between CELAC and the EU, to be 
concluded at a High-Level Meeting between the two 
regions in Quito, Ecuador, in June 2013, which Minister 
White will co-chair with his counterpart from Ecuador. The 
first Technical Meeting involving the 27 EU member states 
and 33 CELAC member states, and co-chaired by Degorah 
Salgado Campana (Ecuadorian Ambassador to the EU) and 
Michael Conroy of Ireland’s Department of Health, took 
place on 17 April. A further such meeting took place in May 
leading up to the High-Level Meeting in June. This High-
Level Meeting will feature a number of thematic debates on 
current global drugs issues. 
This High-Level Meeting follows the ratification of the 
Political Dialogue and Cooperation CAN–EU Agreement 
and Joint Declaration at the 11th meeting of the High-
Level Specialised Dialogue on Drugs CAN-EU, held in 
Quito in October 2012,10 and the Santiago Declaration 
jointly issued in January 2013 by the EU and CELAC and 
renewing their ‘strategic partnership’.11 Paragraphs 35 and 
36 of the Santiago Declaration commit the two regions 
to strengthening co-operation on aspects of the drugs 
issue, including preparations for the 2016 Special Session 
of the UN General Assembly (UNGASS) on the world drug 
problem.
Western Balkans: Since 2003 the EU has had a joint action 
plan with the six countries of the Western Balkans to address 
drug-related problems in the region. These include the 
issue of the ‘Balkan route’ used by drug traffickers between 
Afghanistan and south-eastern Europe. Ireland led the EU 
delegation at a meeting in February and agreement was 
reached that the action plan that expires this year would 
be renewed by means of a Declaration to be signed at a 
High-Level Meeting in November under the Lithuanian 
Presidency.12 Work on the Declaration is progressing at the 
HDG under the Irish Presidency.
United States: The EU meets formally with the United States 
every six months to discuss drug-related matters. A meeting 
under the Irish Presidency was scheduled for May. The 
availability and abuse of prescription and over-the-counter 
drugs were anticipated to feature in the discussions.
Dublin Group: This is an informal consultation and co-
ordination mechanism for global, regional and country-
specific problems of illicit drugs production, trafficking and 
demand. Its participants include the 27 member states of 
the EU, Australia, Canada, Japan, Norway, the United States, 
the European Commission and the UN Office on Drugs and 
Crime (UNODC). The group first met in Dublin in 1990, 
during the fourth Irish Presidency of the EU. It now meets in 
Brussels every six months. Discussion at the meetings focuses 
on the production and trafficking of drugs on a regional 
basis and ways of curbing these activities.13 The Dublin 
Group is due to meet in Brussels during the Irish Presidency 
in June. 
(Brigid Pike)
1. Thanks to Michael Conroy, Dairearca Ní Néill and Brendan 
Ryan of the Drug Policy Unit in the Department of Health for 
generously taking the time to give a briefing on the work of 
Irish Presidency. This briefing formed the basis for this article.
2. Decision No 102/97/EC of the European Parliament and of 
the Council of 16 December 1996 adopting a programme of 
Community action on the prevention of drug dependence 
within the framework for action in the field of public health 
(1996–2000) [Official Journal L 019 , 22/01/1997 P. 0025 
– 0031]. See also T Boekhout van Solinge (2002) Drugs and 
decision-making in the European Union. Amsterdam: Mets and 
Schilt. www.drugsandalcohol.ie/3671/ 
3. Note from the Council of 22 November 2004 on the EU 
Drugs Strategy for the period 2005–2012 [15074/04]. See 
also B Pike (2004) Groundwork for new EU Drugs Strategy 
to be laid during Irish presidency. Drugnet Ireland (10): 1. 
www.drugsandalcohol.ie/11353/ 
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4. Note from the Presidency to the Horizontal Drugs Group on 
3 April 2013 on Draft EU Action Plan on Drugs (2013–2016) 
[5418/2/13 REV 2]. Ireland began drafting the drug action 
plan in late 2012, and built on the work already put in by 
the previous holder of the EU Presidency, Cyprus.
5. For the establishment of the IDIG, see Department of 
Community, Rural and Gaeltacht Affairs (2009) National 
Drugs Strategy (interim) 2009–2016, Dublin: Department of 
Community, Rural and Gaeltacht Affairs, paras. 6.92–6.100 
and Action 61. www.drugsandalcohol.ie/12388/ 
6. Agendas for ‘Meeting of the Horizontal Working Party on 
Drugs’ are available at http://register.consilium.europa.eu 
7. Council Decision 2005/387/JHA (10 May 2005) on the 
information exchange, risk-assessment and control of new 
psychoactive substances. Official Journal of European Union, L 
127/32 (20 May 2005)
8. For details of the European Commission’s work, see Pike 
B (2012) EU drug policies under review in 2012. Drugnet 
Ireland, (41): 8. www.drugsandalcohol.ie/17269/ 
9. For further information on the CSF, visit http://ec.europa.eu/
justice/anti-drugs/civil-society/index_en.htm The CSF’s views 
on the EU drugs strategy 2012–2020 are summarised in 
Pike B (2012) Alternative ways forward for EU drugs policy. 
Drugnet Ireland, (43): 8–9. www.drugsandalcohol.ie/18458/ 
10. CAN comprises four countries in the Andean region – 
Bolivia, Columbia, Chile and Peru. The EU-CAN High-Level 
Specialised Dialogue on Drugs was established in the 
mid-1990s to bring together high-level experts from both 
sides to exchange views on how best to address the drugs 
phenomenon and how to co-ordinate efforts.
11. Council of the European Union (27 January 2013) Santiago 
Declaration. [5747/13. PRESSE 31]
12. Council of the European Union (17 July 2009) Draft Action 
Plan on drugs between the EU and the Western Balkan 
countries (2009–2013). [12185/09]
13. T Boekhout van Solinge (2002) Drugs and decision-making 
in the European Union. Amsterdam: Mets and Schilt, pp. 
114–117. www.drugsandalcohol.ie/3671/
Commission on Narcotic Drugs meets 
for 56th Session 
Between 11 and 15 March 2013 over 1,000 representatives 
from UN member states and civil society met in Vienna 
for the 56th Session of the Commission on Narcotic Drugs 
(CND). The CND is the central policy-making body within 
the UN system dealing with illicit drugs and is the governing 
body for the work of the UN Office on Drugs and Crime 
(UNODC), which is based in Vienna. The CND provides 
member states and civil society with the opportunity to 
exchange expertise, experiences and information on drug-
related matters and to develop a co-ordinated response. 
Holding the EU Presidency (see separate article in this issue), 
Ireland co-ordinated with the European External Action 
Service (EEAS) the EU input to the Session. The CND adopted 
a total of 18 Resolutions, five of which were tabled by the 
EU – forensic drug profiling, HIV/AIDS, Western Africa, an 
electronic import and export authorisation system and drug 
precursors. A Resolution on new psychoactive substances 
tabled by the United Kingdom was co-sponsored by Ireland 
and supported by the majority of EU member states.1 
Preparations were also put in train for the high-level review 
of the implementation of the Political Declaration and Plan of 
Action on International Cooperation towards an Integrated 
and Balanced Strategy to Counter the World Drug Problem 
(2009),2 which will be undertaken during next year’s 
Session. This political declaration and action plan sets 2019 
as the target date for member states to eliminate or reduce 
significantly and measurably the diversion of and trafficking 
in substances frequently used in the illicit manufacture of 
narcotic drugs and psychotropic substances. Thought was 
also given by participants to preparing for the Special Session 
of the UN General Assembly (UNGASS) on the drug problem, 
to be held in 2016, the first such session since 1998 when 
the UN resolved to achieve a drug-free world by 2008. It 
is anticipated that these two reviews will help refine the 
international community’s approach to illicit drugs. 
The view from civil society 
Non-governmental organisations (NGOs) and civil society 
organisations (CSOs) are encouraged to participate in the 
annual sessions of the CND, both before, during and after 
the conclusion of the proceedings.3 This year representatives 
of over 160 CSOs participated. The feedback from two CSOs 
indicate that there has been a sea-change in the approach 
being taken by member states with regard to drug policy.
Canadian Drug Policy Coalition: ‘As the meeting 
commenced it became clear that there was something 
different in the air this year. … My take is that there is an 
implicit if not explicit recognition that the drug policy 
landscape is indeed changing, new approaches are being 
considered, and countries are beginning to demand a wider 
debate on policy. For the CND to remain relevant these 
debates should be welcomed as an important opportunity at 
future meetings of the Commission.’4
International Drug Policy Consortium: ‘These annual 
meetings have long provided frustration for civil society, 
which has fought hard to have a voice in the debates. 
Broadly speaking, however, this year represented an 
improvement on previous events – a further sign that things 
are slowly changing within the United Nations drug control 
structures.’5 
(Brigid Pike)
1. For Session agenda, reports and resolutions, see  
www.unodc.org/unodc/en/commissions/CND/session/56.html
2. High-level segment of Commission on Narcotic Drugs, 
Vienna,11–12 March 2009. Official Records of the Economic 
and Social Council, 2009, Supplement No. 8 (E/2009/28), 
chap. I, sect. C. available at www.unodc.org/documents/
commissions/CND-Uploads/CND-52-RelatedFiles/
V0984963-English.pdf 
3. Vienna NGO Committee on Drugs (2013) The Commission 
on Narcotic Drugs (CND): A briefing for NGOs and CSOs. 
Available at www.vngoc.org 
4. From blog ‘Reading between the lines at the 56th 
Commission on Narcotic Drugs’ by Donald Macpherson, 
Executive Director of Canadian Drug Policy Coalition, posted 
on 27 March 2013 at http://drugpolicy.ca/blog/ 
5. From news alert ‘Feedback from the UN Commission on 
Narcotic Drugs’ posted on 23 March 2013 on web site of 
the International Drug Policy Consortium at http://idpc.
net/alerts/2013/03/feedback-from-the-un-commission-on-
narcotic-drugs 
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in Europe
The European Monitoring Centre for Drugs and Drug 
Addiction (EMCDDA) published their European drug report 
2013: trends and developments on the 28th May.1 This year 
the centre’s annual overview of the European drug situation 
is presented in a new information package designed to  
be ‘more timely, interactive and interlinked’, and which 
replaces the former annual report. The shorter, graphic-
rich report summarises the latest trends across the 27 
EU member states, and Norway, Croatia and Turkey. 
Accompanying the 2013 report is a series of online 
interactive Perspectives on drugs (PODs) providing  
deeper insights into important issues. 
The EMCDDA reports that the numbers initiating heroin 
use are falling, there is less injecting and the use of cocaine 
and cannabis is declining in some countries. While these 
are positive developments, the emergence of new synthetic 
drugs and new patterns of use presents new challenges. 
Today’s drug market is less reliant on the long-distance 
movement of plant-based substances into Europe. 
Globalisation and new technologies have driven significant 
changes in the manufacturing, supply and distribution  
of drugs. 
Commenting on the report, European Commissioner for 
Home Affairs Cecilia Malmström says: ‘I am heartened by 
the fact that, thanks to robust drug policies and record levels 
of treatment, use of heroin, cocaine and cannabis appears 
to be waning in some countries and drug-related HIV 
continues to decline.’ Despite these advances, the fact that 
drug use in Europe remains high is a cause of continuing 
concern. Commissioner Malmström continues: ‘Emerging 
challenges add to my concerns – we are faced with an ever 
more complex stimulant market and a relentless supply of 
new drugs which are increasingly diverse. The fact that over 
70 new drugs have been detected in the last year is proof in 
itself that drug policies need to stay on target.’
The EMCDDA estimates that at least 1.2 million Europeans 
received treatment for illicit drug use in 2011. Opioid users 
constitute the largest group undergoing treatment, followed 
by cannabis and cocaine users. Substitution treatment 
remains the ‘first choice’ for treating opioid dependence. 
Some 730,000 Europeans now receive substitution 
treatment for opioid dependence – up from 650,000 in 
2008 – representing around half of the estimated 1.4 
million problem opioid users in Europe today. Although the 
number of heroin users entering treatment for the first time 
continues to fall, the long-term nature of opioid use means 
that many of those in treatment are likely to require services 
for many years to come.
Cannabis
 ■ Cannabis is still Europe’s most commonly consumed 
illicit drug. However, most countries report stable or 
downward trends among young people. Around 15.4 
million adults aged 15–34 years (11.7% of this age 
group) used cannabis in the last year; 9.2 million of them 
were aged 15–24 years (14.9% of this age group). 
 ■ The use of cannabis by school students aged 15–16 years 
increased between 1995 and 2003, decreased slightly 
in 2007 and has remained stable since then. Around 1% 
of adults, over two-thirds of whom are aged 15–34, use 
cannabis daily or almost daily. 
 ■ Among all clients entering treatment, cannabis is the 
second most frequently reported main problem drug, 
after heroin. Among new clients entering treatment 
for the first time, cannabis is now the most frequently 
reported main problem drug.
 ■ Between 2006 and 2011 the numbers of first-time clients 
increased from 45,000 to 60,000. 
 ■ Herbal cannabis is becoming more common in Europe, 
with almost all countries reporting some domestic 
cultivation of cannabis plants. In 2011 herbal cannabis 
accounted for 41% of all drug seizures, and cannabis 
resin for 36%.
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 ■ Around 197,000 (48%) clients who entered drug 
treatment in 2011 reported opioids, mainly heroin, as 
their primary problem drug. 
 ■ Eleven European countries reported that 11% or more of 
new opioid clients entering treatment were using opioids 
such as fentanyl, methadone and buprenorphine without 
a prescription
 ■ European data on opioid users entering treatment for the 
first time show a fall in numbers from a peak of 59,000 
in 2007 to 41,000 in 2011. 
 ■ Treatment data provides evidence of a long-term decline 
in opiod injecting. The proportion of first-time entrants 
to drug treatment who are opioid injectors fell from 
around 58% in 2001 to 38% in 2011.
 ■ The number of opiate-induced deaths increased from 
2003 up to 2008, stabilised in 2009 and began a decline 
in 2010. The downward trend continued in 2011, when 
6,500 overdose deaths were reported, compared to 
7,000 cases in 2010 and 7,600 in 2009.
 ■ The EMCDDA warns that ‘a large burden of advanced 
liver disease can be expected over the next decade’ 
among injecting drug users (IDUs) infected with hepatitis 
C. Injecting drug use accounts for an average of 58% 
of all hepatitis C virus cases and 41% of the acute cases 
notified across the countries that provided data in this 
area. Three of the countries with national trend data 
for 2006–2011 (Italy, Portugal and Norway) reported 
declining HCV prevalence, while Greece and Cyprus 
reported an increase during this period. 
 ■ There were 1,507 newly report cases of HIV/AIDS 
attributable to drug use in the EU in 2011, a slight 
increase on the 2010 figures. There are significant 
differences in prevalence between countries, with Greece 
and Romania between them accounting for 23% of the 
total. Other countries showed slight increases, while in 
Ireland, Spain and Portugal infection rates have declined 
steadily since 2004. 
 ■ Latest figures for seizures and drug-law offences point to 
an overall decrease in heroin supply. There were 40,500 
seizures of the drug in 2011, down from around 55,000 
in 2010. The 6.1 tonnes of heroin seized in 2011 was the 
lowest reported in a decade and was equivalent to about 
half that seized in 2001. 
Cocaine
 ■ Cocaine remains the most commonly used illicit 
stimulant drug in Europe, although high levels of cocaine 
use are observed in only a small number of western 
European countries. It is estimated that about 2.5 million 
young adults (15–34 years) used cocaine in the last year.
 ■ Recent surveys have shown a fall in the use of cocaine 
by young adults (15–34 years) in countries where use 
among this age group has been highest in earlier years. 
Fewer young adults are using cocaine in Denmark, 
Ireland (2.8%), Spain, Italy and the UK and fewer people 
are entering treatment for the first time with cocaine as 
their main problem drug.
 ■ At least 475 deaths related to cocaine use were recorded 
in 2011. 
 ■ The number of cocaine seizures has fallen steadily in 
recent years. In 2011, 62 tonnes were seized, down 
from 120 tonnes in 2006. There have been some recent 
signs of diversification in cocaine trafficking routes, with 
a drop in interceptions of the drug in the Spain and 
Portugal and increases in Bulgaria, Greece, Romania and 
the Baltic
Other stimulants and new psychoactive substances
 ■ The European Early Warning System (EWS) identified 24 
new psychoactive substances in 2009, 41 in 2010 and 
49 in 2011. In 2012, 73 new psychoactive substances 
were officially notified for the first time, 30 of which 
were synthetic cannabinoids and 14 new substituted 
phenethylamines. 
 ■ An estimated 1.7 million (1.3%) of young adults (15–34 
years) used amphetamines during the past year. Recent 
data show use of the drug to be stable or declining 
among this age group. 
 ■ It is estimated that 1.8 million young adults used ecstasy 
(MDMA) in the last year. Most countries report stable or 
declining levels of ecstasy use between 2006 and 2011. 
Ecstasy was the primary drug used by less than 1% of 
those entering treatment for the first time.
 ■ Between 2006 and 2011 the number of drug supply 
offences related to ecstasy fell by about two-thirds and 
these now represent about 1% of all reported supply 
offences. There is, however, some recent evidence of 
increased availability of MDMA, including high-purity 
MDMA powders. 
(Brian Galvin)
1. European Monitoring Centre for Drugs and Drug Addiction 
(2013) European drug report 2013: trends and developments. 
Luxembourg: Publications Office of the European Union. 
Available at: www.drugsandalcohol.ie/19915/
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profiled
Drug policy in Ireland 
goes back nearly 150 
years. In 1870, when 
Ireland was still part of 
the United Kingdom, 
legislation (the Poisons 
[Ireland] Act) was 
introduced to control 
the sale of various 
substances, including 
opium and morphine. 
Some sixty years later 
the Dangerous Drugs 
Act 1934 was passed in 
order to fulfill Ireland’s 
obligations under the League of Nations Convention for 
Limiting the Manufacture and Regulating the Distribution 
of Narcotic Drugs of 1931. So says a profile of Ireland’s 
drug policy recently published by the European Monitoring 
Centre for Drugs and Drug Addiction (EMCDDA).1
In just 20 pages this drug policy profile examines the 
evolution of Ireland’s drug policy through four historical 
periods: 1921–1979, 1980–1995, 1996–2008 and 2009–
2012. The report explores the country’s national strategies, 
the legal context within which they have operated, the 
public funds spent, or committed, to implement them, 
and the political bodies and mechanisms set up to co-
ordinate the responses to the problem. The profile sets this 
information in context by outlining the size, wealth and 
economic situation of the country as a whole. Also described 
is the manner in which events in Ireland resemble, or differ 
from, developments in other European countries.
Distinctive features of Ireland’s drug policy, according to the 
profile, are the nature of the drug problem that emerged in 
the 1980s and the way in which the government responded. 
The drug problem, which grew rapidly from the early 1980s, 
was mainly located in poor areas of the capital city and was, 
at times, linked with violence and public demonstrations. 
Initially, this led to action at local level which was only 
endorsed considerably later, in a national policy document 
published in 1991. The changes that took place after 1996 
are attributed partly to the work of the Ministerial Task 
Force on Measures to Reduce the Demand for Drugs, which 
recommended the establishment of local drugs task forces, 
but also to external stimuli. The adoption of the Strategic 
Management Initiative (i.e. new public management) across 
government led to the publication in 2001 of a national 
drugs strategy with clear objectives and the use of indicators. 
Similarly, the government’s social partnership approach 
to governing saw stakeholders with different views on the 
drugs issue involved in implementing the national drugs 
policy.
In line with its international obligations, Ireland has a 
‘balanced’ drugs policy. The profile describes how this 
‘balance’ has been achieved:
Consensus among policymakers and other stakeholders 
on the direction of the action taken in supply reduction 
appears to have resulted in the development of 
specialised police forces and new laws to fight organised 
crime. Drug-demand reduction interventions, however, 
especially the more controversial harm reduction 
measures, have often arisen from initiatives at the local 
level, only becoming endorsed and institutionalised at 
national level many years later. The achievement of a 
balance, where supply and demand reduction (including 
harm reduction) have, at least symbolically, similar 
weight, took time to develop… . (p. 31)
The profile notes that the public health approach that drove 
some of the changes in Ireland’s drugs policy in recent 
decades is now giving rise to the question – how can drug 
and alcohol policies in Ireland be better linked? Additionally, 
the development of the ‘legal highs’ phenomenon has 
triggered new legislative developments, which the profile 
comments ‘often focus on those who sell these substances 
and not on those who use them’.
This profile is the second in a series. The first profiled 
Portugal’s drug policy, which has been under the spotlight 
since Portugal decriminalised drug use in 2000.2 This policy 
profile concluded with three observations:
1. The policy reform that occurred in Portugal between 
1999 and 2001 was the result of more than two decades 
of drug policy debate in which there was ongoing 
tension between the criminalisation of drug use and the 
desire to help drug users. Over time the debate moved 
towards a model that prioritises early intervention and 
treatment over any form of sanction. 
2. The decriminalisation of drug use was only one element 
in a larger policy change that progressively transferred 
responsibilities from the Ministry of Justice to the 
Ministry of Health, led to more integrated and detailed 
plans, highlighted the importance of evaluation as a 
policy management tool, and brought alcohol and drug 
policy closer together. These changes have a strong 
public health orientation and the profile suggests that 
this might be the best way to characterise Portugal’s 
drug policy. Rather than representing the Portuguese 
model as a first step towards the legalisation of drug use 
or as the new flagship of harm reduction, the model may 
best be described as a public health policy founded on 
values such as humanism, pragmatism and participation. 
3. Portugal’s drug policy is not proving to be a ‘magic 
bullet’. The profile notes that the country still has high 
levels of problem drug use and HIV infection, and does 
not show specific developments in its drug situation that 
distinguish it from other European countries that have 
a different policy. According to the profile, however, 
Portugal has developed a policy that appears internally 
consistent and that tries to respond to drug problems in 
a pragmatic and innovative way. 
(Brigid Pike)
1. European Monitoring Centre for Drugs and Drug Addiction 
(2013) Drug policy profiles: Ireland. Luxembourg: Publications 
Office of the European Union.  
www.drugsandalcohol.ie/19396
2. European Monitoring Centre for Drugs and Drug Addiction 
(2011) Drug policy profiles: Portugal. Luxembourg: 
Publications Office of the European Union. www.emcdda.
europa.eu/publications/drug-policy-profiles/portugal
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In recent months three reports on the state of Ireland’s 
children, including assessments of their use of tobacco, 
alcohol and illicit drugs, have been published. The statistical 
analyses, undertaken by UNICEF and by the Department 
of Children and Youth Affairs, report that overall levels of 
substance use have declined over the past decade. However, 
the annual review by a group of non-governmental 
organisations of the government’s progress in implementing 
policy suggests that further effort is needed to deliver on 
policy commitments in relation to alcohol policy and the 
effects of alcohol on children. 
Irish children compared to those in other countries, 
2009/2010
UNICEF’s Office of Research has published a comparative 
overview of child well-being in developed countries, 
including Ireland.1 Drawing on statistical data relating 
to 2009–2010, the report ranks Ireland 10th out of 29 
countries. Well-being is based 
on an aggregate of five separate 
dimensions, on some of which 
Ireland scores very well and 
on others not so well: material 
well-being (17th), health and 
safety (15th), education (17th), 
behaviours and risks (7th) and 
housing end environment (2nd). 
The ‘risk’ dimension comprises  
four indicators – smoking, alcohol 
and cannabis use, and teenage 
fertility rate. 
Regarding risk behaviours, the following three graphs from 
the UNICEF report indicate that smoking and cannabis use, 
and getting drunk, among young people in Ireland, as in 
most other developed countries, have all declined.
Figure 7.3a Changes between 2001/2002 and 2009/2010 in the percentage of young people aged 11, 13 and 15 
who reported smoking at least once a week
2001/2002
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Figure 7.3b Changes between 2001/2002 and 2009/2010 in the percentage of young people aged 11, 13 and 15 
who reported having been drunk on more than two occasions
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Figure 7.3c Changes between 2001/2002 and 2009/2010 in the percentage of young people aged 11, 13 and 15 
who reported having used cannabis in the last 12 months
Note: No data available for Norway in 2001/2002.
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9How are the children? (continued)
State of the 
Nation’s Children, 
2012
Released in March 
2013, this fourth 
biennial State of the 
Nation’s Children 
report,2 published 
by the Department 
of Children and 
Youth Affairs, 
presents data in four 
sections:
1. Socio-demographics – the child population, child 
mortality, family structure, parental education level, 
Traveller children, foreign national children, children with 
a disability and children as carers. 
2. Children’s relationships – with their parents and peers, 
including levels of reported bullying and children’s 
friendships. 
3. Children’s outcomes – relating to health, education, and 
social, emotional and behavioural outcomes, including 
smoking, alcohol and cannabis use. 
4. Formal and informal supports – including school, 
housing, antenatal care, immunisation and economic. 
Data on smoking and 
alcohol and cannabis 
use were derived from 
The Irish health behaviour 
in school-aged children 
(HBSC) study 2010, and 
the results compared with 
the data from previous 
iterations of the HBSC.3 
The report highlighted 
the decrease in the use 
of all three substances by 
children aged 10–17 in 
Ireland:
 ■ The percentage who 
reported never having 
smoked increased from 50.8% in 1998 to 73.5%  
in 2010. 
 ■ The percentage who reported never having had an 
alcoholic drink increased from approximately 40% in 
2002 to 54% in 2010.
 ■ The percentage who reported having taken cannabis 
at least once in their lifetime decreased from 15.7% in 
2006 to 10.5% in 2010. 
The report points out that Traveller children and children 
with a disability and/or chronic illness were less likely than 
other children to report having never smoked cigarettes 
or drunk alcohol. They were also more likely, along with 
immigrant children, to report having taken cannabis at least 
once in their lifetime. 
With regard to age, gender and social class, the report notes 
that older children and boys were less likely to report never 
having smoked cigarettes, had an alcoholic drink or taken 
cannabis. Children from lower social class categories were 
similarly less likely to report never having smoked cigarettes 
or taken cannabis. However, the percentages of children 
never having had an alcoholic drink were broadly similar 
across all social class categories.
Is government keeping its 
promises to children? 
The Children’s Rights Alliance 
(CRA) has published its fifth 
annual report on the state 
of the nation’s children.4 
The report assesses the 
government’s performance in 
honouring its promises to the 
over one million children living 
in Ireland. Awarding ‘Ds’ for 
each of the first three years, 
2008–2010, the CRA gave the 
government a ‘C+’ in 2011, 
reflecting ‘the Government’s 
commitment to children’s 
rights, evidenced in the appointment of a Minister for 
Children and Youth Affairs with full cabinet status; the 
creation of a new Department of Children and Youth Affairs; 
and the commitment to hold a referendum on children’s 
rights’. In the latest report, for 2012, the CRA has given an 
overall ‘C’ grade, reflecting ‘a satisfactory attempt to date, 
though children remain wanting’.
Notwithstanding the improvement in the overall rating, 
under the subheading ‘Right to Health’, the report gives the 
government a ‘D’ for progress in 2012 in relation to alcohol, 
drugs and smoking, pronouncing progress ‘unsatisfactory’. 
The report states that despite the commitment that every 
government department, agency or task force responsible 
for implementing elements of the National Addiction 
Strategy would be required to account to the minister for 
their budget annually and to demonstrate progress on 
achieving targets, a National Addiction Strategy has not been 
published and ‘is not expected until 2016’. The report goes 
on to comment that ‘there is no Government policy on 
tackling alcohol misuse; no Government decision has been 
made on recommendations of the Steering Group’. It calls 
for the following actions in 2013: 
 ■ Urgently adopt a national strategy to tackle alcohol 
misuse and ensure it is coherent with the Interim 
National Drugs Strategy 2009–2016. The strategy should 
have a clear focus on the impact of alcohol and drugs 
on children, including to reduce children’s access to 
alcohol and drugs; curb the widespread availability of 
cheap alcohol; restrict the promotion of alcohol; raise 
awareness of the potential harmful effects of alcohol 
and drugs and develop youth appropriate addiction 
treatment services. It must also address harmful parental 
drinking and its impact on children. The Strategy 
must be accompanied by a clear plan, with targets, 
timeframes and accountability structures.
 ■ Introduce a legislative ban to protect children from 
alcohol marketing.
drugnet 
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 ■ Sustain investment in non-alcohol and drug free spaces 
for young people.
 ■ Enact the Protection of Children’s Health from Tobacco 
Smoke Bill 2012.
(Brigid Pike)
1. UNICEF (2013) Child well-being in rich countries: a 
comparative overview. Innocenti Report Card 11. Florence: 
UNICEF Office of Research. www.drugsandalcohol.ie/19663 
2. Office of the Minister for Children and Youth Affairs (2012) 
State of the nation’s children report: Ireland 2012. Dublin: 
Stationery Office. www.drugsandalcohol.ie/19449 
3. Kelly C, Gavin A, Molcho M and NicGabhainn S (2012)  
The Irish health behaviour in school-aged children study 2010. 
Dublin: Department of Health and National University of 
Ireland, Galway. www.drugsandalcohol.ie/17360. For a 
detailed account of the HBSC 2010 data relating to alcohol 
and cannabis use, see Long J (2012) Alcohol and cannabis 
use among school-aged children in Ireland. Drugnet Ireland, 
(42): 1–2. www.drugsandalcohol.ie/17680 
4. Children’s Rights Alliance (2013) Report card 2012. Dublin: 
Children’s Rights Alliance. www.drugsandalcohol.ie/19332
How are the children? (continued)
The President gets young people 
talking…
In his inauguration speech on 11 November 2011 President 
Michael D Higgins said that as part of his
presidency he would host a number of seminars on themes 
that went beyond immediate legislative demands but which 
were important to the shared life of the Irish people. He 
decided that the first 
of these seminars 
would be about 
’Being Young and 
Irish’.
President Higgins 
invited young people 
to think about the 
way we wish to live 
with others; the 
way our institutions 
must work and serve 
their purpose for the 
welfare of all; the 
way we define what 
is valuable; and how 
the economy should 
connect with society. 
A total of 775 people aged between 17 and 26 years 
contributed their ideas and opinions by participating in 
regional workshops, making separate submissions and/
or participating in the final seminar. The published report 
highlighted nine areas of concern:1
 ■ Employment, enterprise, social security, concern with the 
economy
 ■ Political reform
 ■ Education
 ■ Equality
 ■ Involve young people
 ■ Being positive
 ■ Health
 ■ Community and civil society
 ■ Identity as Irish
A summary of the issues raised in relation to alcohol, drugs 
and smoking, which were reported under the heading of 
Health, is given below.1 
Alcohol
Most saw the role of alcohol in Irish society, and in relation 
to young people in particular, as problematic. For example: 
‘Alcohol is the drug of choice among youth. Many young 
people are experiencing the consequences of drinking too 
much, at too early an age. As a result, underage drinking is 
a leading public health problem in this country.’ Alcohol was 
seen as affecting all areas of people’s lives – work, socialising, 
sport, addiction and mental health. One participant blamed 
those selling alcohol for the under-age availability: ‘Alcohol is 
so widely available these days that employees don’t ask the 
customers for ID anymore.’ 
Measures identified to tackle the alcohol problem included 
the provision of alternative and affordable options for 
socialising. For example: ‘If I’m completely honest it’s not 
fun living here. There is a great lack of facilities for young 
people and more often than not most of us resort to drink to 
fool ourselves into thinking that we are having fun. In reality 
we spend much of our time on the computer developing a 
sort of artificial social life, devoid of face-to-face interaction.’ 
Other suggestions included more education, for example 
sending secondary school students into hospitals to see 
the effects of alcoholism and substance abuse, or student 
campaigns about the effects of alcohol. Higher taxes on 
spirits, wines and shots were mentioned. Conversely, cutting 
taxes on alcohol sold in drinking establishments such as 
pubs, night clubs and restaurants was recommended, as well 
as simultaneously raising taxes on alcohol sold in off licences: 
it was argued that this would both support the declining 
pub trade and reduce the sale of alcohol in off-licences 
and shops, which were seen as the main problem since 
consumption of drink is then unsupervised. 
Drugs
Only a small number of participants commented on drugs, 
with very little consensus. Some submissions related to the 
harm caused by drugs while some focused on the harm 
caused by the illegal status of drugs. The participants gave a 
number of different arguments for legalising drugs, especially 
cannabis. Overall, it was argued that if drugs were legalised, 
they would be safer: ‘If legalised there “would not be as much 
of a black market”, therefore, “less organised crime related 
to drugs … crimes like robbery and the likes because prices 
would be lower without the criminals involved”.’
One participant claimed that cannabis ‘has no reported 
deaths or illness’, and that the laws governing cannabis use 
need to be changed because, ‘it’s disgraceful that a toxic 
drugnet 
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The President gets young people talking… (continued)
substance [alcohol] which is the cause of a lot of domestic 
and social problems as well as mental and physical illnesses 
is legal while a non toxic substance which many Irish people 
chose to smoke is illegal. It’s a waste of tax payers money 
… [which is] negatively effecting many young people … 
receiving a criminal record for possession of this relatively 
harmless drug.’
While the call for legalisation focused mainly on cannabis, 
a couple of participants called for ‘complete legalisation of 
all drugs’, with strict regulation especially for ‘hard drugs’. 
Some young people were firmly of the belief that the 
‘system’ was ‘enabling … evil people by having the drug 
illegal’. The need for regulation was emphasised, including a 
strictly controlled minimum age for use and the use of photo 
ID or swipe cards.
Smoking
A small number of ‘passionate’ comments, all negative, 
were provided about smoking. One participant proclaimed, 
‘I believe in the 21st century it is a failure of a nation that 
young people still smoke’, while another stated, ‘the goal 
should be to completely eradicate smoking from Ireland’. 
Participants expressed frustration that smoking has not 
been tackled effectively by society: ‘campaigns based on 
“MPOWER”2 may marginally reduce the number of smokers, 
but is … extremely inefficient based on the number of 
smokers in the country’. One participant suggested that 
smoking could be completely phased out in a generation.
(Brigid Pike)
1. Centre for Social and Educational Research, Dublin Institute 
of Technology (2013) Being young and Irish 2012: take 
charge of change. Report on President Michael D Higgins’ 
consultation ‘Being Young and Irish’ with young people. 
Dublin: Office of the President.  
www.president.ie/youngandirish/ 
2. MPOWER is a package of six evidence-based tobacco control 
policies promoted by the World Health Organization which 
has been incorporated by the HSE in its Tobacco Control 
Framework.
…and the Minister replies
On 21 March 2013 the Minister for Health, James Reilly TD, 
gave his thoughts on the report published by the Office of 
the President Being young and Irish: take charge of change, 
and explained what he was doing to help realise the young 
peoples’ vision for Ireland. He said that he shared the young 
people’s concerns and listed the initiatives being progressed 
by his department.1
Alcohol
The minister reported that ‘real and tangible proposals’ 
were being finalised on foot of the recommendations in 
the report of the Steering Group on a National Substance 
Misuse Strategy 2012, mainly in the areas of legislation on 
minimum unit pricing, access to and availability of alcohol, 
advertising and sponsorship. He noted that the Cabinet 
Committee on Social Policy had also considered the matter 
and was to bring forward specific proposals for consideration 
by government as soon as possible. In the meantime, work 
on developing a framework for the necessary Department of 
Health legislation was continuing.
Legalising cannabis
The Minister’s reply is given here verbatim:
International research shows that significant physical 
and mental health risks are associated with long-term 
cannabis use. These include increased risks of developing 
lung and throat cancer (smoke from cannabis contains 
more carcinogenic tars than does tobacco smoke) and 
risks associated with the development of mental illness, 
such as schizophrenia and depression. The potency 
of cannabis products can also vary greatly. The 2011 
NACD study The potency of THC in cannabis products 
reported the growing concern about the significant rise 
in the potency levels in some cannabis products over 
the last number of years, particularly in herbal cannabis. 
Concerns have also been raised that cannabis produced 
in Ireland, and used relatively quickly, has a higher 
potency than imported varieties. There is also evidence 
that cannabis plants generally are being genetically 
engineered to ensure they produce high levels of THC 
(tetrahydrocannabinol). Legalisation would be likely 
to lead to greatly increased levels of experimentation, 
leading to significantly increased levels of sustained 
long term use causing increased health problems in 
our society. Indeed, the situation that pertained only a 
few years ago in Ireland in regard to the volume of new 
psychoactive substances sold in headshops illustrates this 
point. People were prepared to experiment with readily 
available legal products, despite the publicity regarding 
the consequences. Legalisation would be unlikely to 
significantly reduce the level of criminality surrounding 
the broader market in illicit drugs. Also, if cannabis was 
legalised, it would most likely be strongly regulated 
and probably heavily priced to influence demand (as 
in the case of tobacco). This in turn could lead to the 
continuation of an illicit market on similar lines to the 
black market of cigarettes. Overall, the amount of money 
likely to be raised in tax would be small in relation to the 
health and other implications arising. Cannabis was re-
classified from a Class C drug to a Class B drug in the UK 
in 2009. This decision was taken in the light of the “real 
public concern about the potential mental health affects 
[sic] of cannabis use, in particular the use of stronger 
forms of the drug. 
Finally, any possibility of legalising cannabis has to be 
looked at in a European and global context. A unilateral 
decision to legalise its use here would most likely lead 
to Ireland becoming a destination for those from other 
countries who wish to use cannabis. In view of the 
evidence available I am not in favour of legalising the use 
of cannabis at this time.
Tobacco
The Minister stated that his department was developing a 
new tobacco policy with the aim of ‘denormalising’ tobacco 
smoking and so leading to a tobacco-free society. The new 
policy will have a particular emphasis on children. It is 
envisaged that the policy will be completed by mid-2013. 
(Brigid Pike)
1. Reilly, J (2013, 21 March) Parliamentary Debates Dáil Éireann 
(Official report: unrevised): Written answers. Presidential 
reports. Vol. 797, No. 2, p. 561. Question(s) 253.  
http://oireachtasdebates.oireachtas.ie/Debates%20A...
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Young people appeal for a more 
inclusive society
The Department of Children and Youth Affairs (DCYA) recently 
published a summary of the main issues to arise from a regional 
consultation with 239 young people in Sligo, Cork and Dublin; 57% 
were female and 73% were aged under 18 years.1 The consultations 
were undertaken as part of a European programme called 
‘Structured Dialogue’, a process established by the Council of the 
European Union in its resolution for a renewed framework for co-
operation in the youth field (2010–2018). The consultations centred 
on the theme of ‘social inclusion’ among young people and the 
main issues are presented here under a number of sub-headings. 
What does being included mean?
A synopsis of the issues covered in Table 1 show that young people 
feel included when their uniqueness as individuals is recognised and 
respected, when their opinions are actively sought and responded 
to, when they are afforded equal dignity and respect as that shown 
to others and when the can form attachments and bonds with 
significant others. 
Table 1 Components of social inclusion for young people
Site of inclusion Illustrative examples of being included
Among your family and friends Being respected and not treated like a child in the family  
Being accepted and loved for who you are  
Having a safe space to be yourself  
Having a say and being included in decisions  
Having someone to talk to and rely on
In your area (local community) Being consulted for your opinion  
Being treated the same as older people  
Getting involved in community events  
Having a sense of belonging and feeling included  
Having a fun and safe place to hang out with friends
Employment Being treated equally regardless of age, gender, sex and race  
Fair wage and reward  
Having equal opportunities for training and promotions  
Being trusted and given responsibility  
Being involved in decision-making
Education Equal access and funding for education regardless of social class  
Equality – no racism, bullying, discrimination or judgement regardless of sexuality, 
race, religion or background  
Having a voice on important things in school  
Being treated fairly by teachers
Clubs and activities A sense of belonging and feeling welcome  
Being consulted, listened to and involved in decision-making on activities  
Being treated equally and not judged, discriminated against or bullied  
Meeting new people and making friends  
Working as part of team 
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Young people’s voices (continued)
What stops young people being included?
As illustrated in Table 2, young people feel excluded when their significant others do not afford them trust and respect and do 
not legitimately recognise their differences, and when they experience bullying and discrimination due to their differences. 
What times in their lives are young people most at risk of being excluded?
Table 3 illustrates that at important milestones in their lives young people can experience elevated risks which can contribute 
to their feeling excluded. 
The report documents a large number of achievements that 
young people claim they secured through participation in 
youth-related clubs and activities. These are listed under three 
broad categories (i) personal development and happiness (ii) 
skills and experiences needed for life and (iii) feeling more 
included. Young people talked about how participating in 
youth-related clubs and activites helped them ‘to discover 
who they are, “what they want from life”, and to accept 
themselves for who they are by building self-confidence and 
self-esteem. In addition, “young people feel that clubs give 
you an opportunity to talk to people you wouldn’t talk to 
otherwise”, resulting in respect, tolerance and acceptance of 
others and their differences’ (p.9). 
When young people were asked for their views on how the 
existing activities could be improved, and new ideas for clubs 
and activities, the main responses centred on young people 
having a more active say in running clubs and activities, more 
interaction with similar groups outside the clubs, greater 
diversity of activities in clubs and an emphasis on providing 
a welcome to new members and a safe space in clubs to 
address specific issues, such as disability, sexual health and 
orientation. 
This is useful snapshot of the lives of young people which 
illustrates their strong desire to be recognised for their unique 
individuality and their enthusiasm and willingness to build 
a more relevant and meaningful understanding of the main 
issues confronting young people in contemporary society. 
Their appeals for a respect for difference and for justice 
and equality are striking and their testimony to the value of 
participation in youth sector related activities is encouraging. 
(Martin Keane) 
1. Department of Children and Youth Affairs (2013) Young 
voices: have your say. Summary report. Dublin: Department of 
Children and Youth Affairs.  
www.drugsandalcohol.ie/19479
Table 2 Components of social exclusion for young people 
Site of exclusion Illustrative examples of not being included
Among your family and friends Negative relationships with parents due to lack of trust and respect  
Negative relationships with friends and peers due to peer pressure, alcohol and drug 
misuse and different values, beliefs and interests  
Discrimination – being judged on your looks or your sexual orientation
In your area (local community) Stereotyping of and discrimination against young people by older people, e.g. the 
media, Gardaí  
Bullying  
Lack of facilities, e.g. a place to hang out and lack of information on existing facilities  
Peer pressure to drink alcohol, take drugs and get involved in crime 
Employment Lack of work for young people and lack of opportunities to gain experience  
Lack of opportunities to get necessary, qualifications, education and skills  
Discrimination on age, gender, race, ethnicity, disability, sexuality, religion, mental 
health and criminal record 
Education Bullying by other students due to looks, race, religion or sexuality  
Discrimination and lack of understanding of sexuality e.g. religion class teaches that 
‘being gay is wrong’  
Bad teachers e.g. strict and controlling  
Too expensive
Clubs and activities Bullying and cliques, e.g. ‘Group closure’  
Not being made welcome – due to sexuality, social background, and cultural 
differences  
Club can be intimidating, have narrow range of activities and be expensive to attend  
Lack of confidence and self-esteem  
Rural isolation due to lack of transport 
Table 3 Significant life events and risk among young people
Significant life events Illustrative examples of being at-risk of exclusion
Starting primary school Leaving parents for the first time, meeting new teachers and friends and adapting to 
the playground 
Starting secondary school Meeting new teachers and new people and adapting to new schools and systems 
Teenage years Puberty, discovering sexuality and identity, dealing with fractured relations with family 
and friends and dealing with peer pressure and alcohol and drugs, bullying and being 
judged 
Transition year An ‘in-between’ stage and staring a social life 
Exam time Pressure from parents to get points and fear of failure 
Starting college Lack of financial support, new relationships, thinking about the future, leaving home 
and becoming independent 
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Guidelines for promoting mental health 
and suicide prevention in post-primary 
schools
A comprehensive set of guidelines promoting positive 
mental health and well-being among post-primary students 
was recently launched.1 The guidelines were developed 
by an inter-departmental group of representatives from 
the Department of Education and Skills, the Health Service 
Executive and the Department of Health. The guidelines 
were developed in three phases: (i) a national consultation 
process with key stakeholders from health, education 
and other relevant sectors; (ii) a review of national and 
international literature on good practice in health promotion 
and suicide prevention and (iii) developing the guidelines 
using information gathered from the consultation process 
and the literature review through on-going discussion with 
key partners. The purpose of developing the guidelines is 
to support schools to develop a whole-school approach to 
promoting positive mental health and preventing suicide. 
The guidelines are based on the theoretical assumptions 
that developing positive mental health and well-being, 
linked to a sense of attachment and bonding to school, will 
foster improved resilience and social skills among students. 
Schools are encouraged to promote positive mental health 
and well-being through adopting a whole-school approach; 
this means permeating all aspects of school-life from the 
curriculum to relations between staff and students and 
via the school environment. The guidelines provide some 
examples of models of good practice in this area. 
One such model is the Health Promoting School 
(HPS) model which include four areas of action within 
which schools can promote positive health; the school 
environment, including social relations and physical 
characteristics; the school curriculum by including health 
promotion modules and learning e.g. SPHE; school policies, 
e.g. anti-bullying and substance use policies; and forming 
partnerships between the school and the wider community. 
The guidelines clearly outline the eleven stages that schools 
adopting the HPS model can commit to. The guidelines also 
state that ‘the full implementation of Social, Personal and 
Health Education (SPHE) and Relationships and Sexuality 
Education (RSE) provides a framework for educating young 
people about their health and well-being in a planned and 
structured way’ (p.21). The guidelines also recommend 
that schools should adopt the three-tiered continuum of 
support model for promoting mental health: support for all 
(universal), support for some (selective) and support for a 
few (indicated). 
School support for ALL 
Section three sets out guidelines on how schools can 
implement a whole-school approach to promoting positive 
mental health for all members of the school community, 
providing early identification and intervention for young 
people showing mild or transient signs of difficulty. Schools 
are encouraged to undertake self-evaluation to establish 
what is working well, where improvement is needed, and to 
evaluate and report on outcomes. 
School support for SOME 
Section four sets out guidelines on how schools can identify 
young people who are at risk of developing unhealthy 
patterns of behaviour or who are already showing early signs 
of mental health difficulties. Issues that can place young 
people at an elevated 
risk level include 
bereavement, bullying, 
family problems, 
discrimination, 
sexuality and 
substance use. Schools 
are encouraged to 
gather sufficient 
relevant information 
on the issue/s 
that concern the 
young person, 
plan and execute 
an appropriate 
intervention and 
undertake a regular 
monitoring and review 
of the overall situation. 
School support for a FEW
Section five sets out guidelines on how schools can support 
young people with complex or enduring needs relating to 
their mental and emotional well-being. Supports at this level 
will be more intensive and individualised and may include 
the use of external professionals and services. This section 
provides guidance on how to support young people to 
return to school following an absence for mental-health-
related issues,as well as those at-risk of suicidal behaviour 
and those who need support in the aftermath of a death by 
suicide. 
Overall, this is a very useful resource for post-primary 
schools to draw upon when devising plans to prevent or 
tackle existing mental health difficulties among students. 
The resource is conceptually rich in identifying the key 
risk factors that may compromise a young person’s 
mental health and the protective factors that can develop 
resilience to counteract pressures on their mental health. By 
situating potential responses within the three-dimensional 
classification of universal, selective and indicated prevention, 
there is ample scope for schools to develop responses to 
tackle issues that affect the whole school population, in 
addition to putting in place measures to support young 
people who may have a higher risk profile around their 
mental health. Using these guidelines to develop frameworks 
of understanding of the pressures that can impact on young 
people’s mental health and how schools can respond in 
a timely and effective manner is key to their successful 
implementation. Indeed, in the concluding section, the 
report states that ‘it is vital that school management 
and staff review and build on existing good practice and 
implement the processes described in these guidelines to 
support the emotional health of young people’ (p.51).
(Martin Keane) 
1. Department of Education and Skills, Health Service 
Executive, and Department of Health (2013) Well-being in 
post primary schools: guidelines for mental health promotion 
and suicide prevention. Dublin: Department of Education and 
Skills, Health Service Executive & Department of Health. 
www.drugsandalcohol.ie/19228
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Healthy Ireland – implementation 
matters
On 28 March 2013 
the government 
launched Healthy 
Ireland: a framework 
for improved health 
and wellbeing 
2013–2025.1 Healthy 
Ireland sets out a 
framework of actions 
to improve health 
and wellbeing and 
reduce the health 
risks posed to future 
generations. The 
government has 
developed the policy 
in response to rising 
levels of chronic 
illness, lifestyle trends 
that threaten health and persistent health inequalities.
The economic justification for the policy is clear. It is 
estimated that in Ireland the economic cost per year 
associated with obesity, smoking, alcohol use and mental 
health issues is around €18 billion. (The economic cost of 
the illicit drugs market in Ireland has never been calculated.)
Evidence and experience from around the world show that 
in order to make a positive change in population health and 
wellbeing a whole-of-government approach is needed, as 
well as involving local communities and society as a whole. 
Healthy Ireland lists 64 broad inter-sectoral actions, with 
initial partners including government departments, statutory 
agencies, civil society organisations, the community 
and voluntary sector, the private sector, and employee 
representative organisations. 
The authors of the policy framework recognise that ensuring 
effective implementation of the policy, making sure it 
does not get left on a shelf, is the biggest challenge.2 The 
framework of actions emphasises five activities – leadership, 
measurement, partnership, empowerment, and resource 
management – designed to ensure the policy remains on the 
front burner.
Leadership: The Cabinet Committee on Social Policy, 
chaired by An Taoiseach, will oversee implementation. It will 
oversee and monitor targets and action plans to improve 
health and wellbeing and will address the cross-cutting 
policy issues that arise. A national Healthy Ireland Council 
will be established to represent all stakeholders. This Council 
will build a network of advocates at national and local level 
to actively promote and pursue the goals of Healthy Ireland.
Measurement: Rigorous planning, reporting and evaluation 
will be assured through an Outcomes Framework with key 
indicators and measurable targets. Indicators will be set to 
measure improvements in population health. These will 
include health status, weight, diet and activity levels. It will 
also include indicators to measure health inequalities and 
the broader determinants of health, such as the proportion 
of young people completing second level education, access 
to green spaces and other environmental influences; and 
indicators that measure how we are protecting the health of 
the population, e.g. uptake of immunisation programmes.
Partnership: Responsibility for action on health 
determinants and health behaviours will be distributed 
across the State, private sector and employers, communities, 
families and individuals. Local structures will be identified 
and supported to work on common implementation 
agendas. It is at this level that individuals, community and 
voluntary groups and projects, sporting partnerships, local 
schools, businesses, primary care teams, community gardaí 
etc. will be able to work together.
Empowering people and communities: To achieve the goal 
of a ‘healthy Ireland’, it is essential to empower people and 
communities to improve and take responsibility for their own 
health and wellbeing. Actions to empower individuals and 
communities will need to be balanced with a broader range 
of provisions influencing the choices people have, e.g., 
regulatory and legislative options to adapt or change the 
decision-making environment or to provide for quality and 
safety standards. Social interaction and social connectedness 
and involvement in community life are also keystones to 
empowering people at the individual level and building 
strong communities for health and wellbeing, and will be 
addressed.
Obesity: Two in every three adults in Ireland are overweight or obese, and 20% of children in all socio-economic groups 
are overweight.
Smoking: Around 1 million people in Ireland smoke tobacco products, and 12% of children aged between 11 and 17 
years are current smokers. Smoking rates are highest (56%) among women aged 18–29 years from poor communities, 
compared to 28% of young women from higher social classes. One in every two smokers will die of a tobacco-related 
disease; 5,200 preventable deaths occur each year from tobacco. 
Alcohol: The alcohol consumption rate for Ireland is one of the highest in Europe, at 11.9 litres per capita. Alcohol is 
responsible for approximately 90 deaths every month, and is a factor in half of all suicides. 
Drugs: Use of illegal drugs in the last year is reported at 7% of adults aged between 15 and 64 years, and drug use was the 
direct or indirect cause of 534 deaths in 2008.
Mental health: Mental health is a growing health, social and economic issue and it is expected that depressive mental 
illnesses will be the leading cause of chronic disease in high-income countries, including Ireland, by 2030. Currently, in 
Ireland, the mortality rate from suicide in the 15–24-year age group is the fourth highest in the EU. One in 20 participants 
in an Irish longitudinal study on ageing (TILDA) reported a doctor’s diagnosis of depression, with a similar number 
reporting a diagnosis of anxiety. Levels of depression and admission to psychiatric hospital are higher among less affluent 
socio-economic groups.
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Resource management: Healthy Ireland will be 
implemented using existing resources; existing programmes 
and priorities will be reviewed to ensure they are directed 
toward community-based programmes for those most at 
risk or experiencing the greatest disparities, and to ensure 
selection of those programmes with the greatest opportunity 
for impact. 
How Healthy Ireland will work in with the National Drugs 
Strategy remains to be seen. With regard to alcohol, citing 
the 2012 report of the Steering Group on a National 
Substance Misuse Strategy, Healthy Ireland identifies a 
decrease in alcohol consumption across the population as an 
indicator and sets a target of reducing the amount of alcohol 
consumed by people over the age of 15 years to an annual 
per capita consumption of 9.2 litres of pure alcohol. No date 
is set for this target. 
(Brigid Pike)
1. Department of Health (2013) Healthy Ireland: a framework 
for improved health and wellbeing 2013–2025. Dublin: 
Department of Health.  
Available at www.drugsandalcohol.ie/19628 
2. The challenge of effective implementation has been recognised 
and written about elsewhere. For example, see Pike B (2010) 
How effectively is policy being implemented? Drugnet Ireland, 
(33): 15–16 (www.drugsandalcohol.ie/13029),  
and Burke K, Morris, K and McGarrigle L (2012) An introductory 
guide to implementation: terms, concepts and frameworks. 
Dublin: Centre for Effective Services.  
Available at www.effectiveservices.org/knowledge-exchange/
ces-publications 
Healthy Ireland (continued)
Alcohol Forum national conference
As part of National Alcohol Awareness Week, which took 
place from 18–22 March, the Alcohol Forum hosted a 
conference in the Convention Centre, Dublin, on 20 
March entitled The Power of Local Community in Reducing 
Harmful Drinking. Pat Harvey, Chairman of the Alcohol 
Forum provided the opening address and outlined the costs 
associated with alcohol-related harm in Ireland. He spoke 
about the influence of the alcohol industry, describing it as 
‘a “Goliath” in terms of muscle and funds nurturing a society 
that has alcohol consumption at dangerous and harmful 
levels’. He called on the government to implement the 
National Substance Misuse Strategy as a matter of urgency.1 
Mr Alex While TD, Minister of State for Primary Care, opened 
the conference and spoke about the power of community 
and the need to mobilise communities, schools, sports and 
law enforcement and to pool resources. He said that the 
alcohol problem in Ireland was too big and too entrenched 
to be dealt with on an individual or even a community 
level and that, despite the arguments being made against 
every single measure that has been proposed, some form of 
regulation was necessary. He confirmed that the government 
was considering the measures contained in the Steering 
Group report on a National Substance Misuse Strategy and 
would announce its conclusions and decisions shortly.2
Other speakers included Dr Ann Hope, Department of 
Public Health and Primary Care, Trinity College Dublin; 
Dr Walter Kern Scheffeldt, Clinical Psychologist, Zurich 
University of Teacher Education; Anne Timony, Community 
Mobilisation Officer with the Alcohol Forum; and Claire 
Dineen, Chair of the National Forum of the Family Resource 
Centre Programme. There was also a ‘Soapbox’ session 
where speakers were given three minutes to present their 
arguments on how to effect changes. The participants in 
this session were Fiona Ryan, CEO, Alcohol Action Ireland; 
John Waters, Irish Times columnist; John Logue, President of 
the Union of Students in Ireland; Denis Bradley, former Vice 
Chair of the Northern Ireland Policing Board; and Eamon 
O’Kane, Director of Derry Healthy Cities. 
(Deirdre Mongan)
1. Alcohol Forum (2013, 20 March) Alcohol Forum challenges 
government, the drinks industry & parents. News item posted 
on the Alcohol Forum website. Accessed 8 May 2013 at 
www.alcoholforum.org/index.php/news/103
2. White A (2013, 20 March) The power of local community in 
reducing harmful drinking. Speech delivered at the opening 
of Alcohol Forum conference, 20 March 2013, Convention 
Centre, Dublin. Accessed 8 May 2013 at  
http://alexwhitetd.wordpress.com/2013/04/11/
Minister Alex White TD with Alcohol Forum chairman  
Pat Harvey at the opening of the conference (photo by  
Conor O'Mearain)
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Education, addiction services and 
workforce development
A recent National Documentation Centre conference1 heard 
researchers, educators and service managers speak on 
the role of education in the development of the addiction 
services workforce. Education and training are essential 
elements in the development of a skilled, competent 
and motivated workforce. Employing organisations must 
recognise the value of this learning and encourage their 
staff to use it in an innovative and progressive environment. 
The NDC conference speakers addressed these issues from 
different perspectives and a number of broad themes 
emerged during the course of the day. These themes are set 
out below. 
1. Using evidence in addiction work
An evidence-based approach must involve a critical 
assessment of current and proposed practices and a 
thorough analysis of the context of the particular problem 
that needs to solved. Interventions can then be chosen 
on the basis of the evidence of efficacy, their suitability 
for the population requiring the intervention and the 
capacity of the service to implement the intervention using 
established protocols. Education and training programmes 
should include some element of critical appraisal training 
to encourage a questioning attitude and to challenge the 
establishment of new orthodoxies. 
2. The role of educational institutions in developing the 
addiction workforce
A number of educators working in third-level institutions in 
different parts of the country described the courses which 
these institutions supported and the outlook on which they 
had been established. Learning in this setting allows students 
to benefit from the accumulated educational knowledge 
of the university or college and from the intellectual 
resources built up across a range of disciplines. Availing 
of these resources enables the learner to develop a keener 
awareness of the social, political and economic contexts in 
which their new skills will be applied. It is also beneficial to 
study in an environment in which a spirit of enquiry and 
multi-disciplinary approaches to problem solving are the 
norm and critical abilities and intellectual development are 
encouraged. 
One course director noted that it is now common for 
universities to assert their responsibility to the broader 
community and to highlight their work in outreach and 
adult education work. 
A significant proportion of the cohort undertaking courses 
in drugs and alcohol studies would otherwise be unlikely to 
study at third level. By supporting these courses, and the 
tutors and academic staff that provide them, the university 
gives real expression to the values of inclusiveness and equal 
opportunity it officially supports. 
3. Developing competencies
It was suggested that an over emphasis on collecting 
quantifiable and comparable data brings with it the risk 
of masking less tangible but still vital knowledge. An 
academic who has worked in adult education for many years 
distinguished three separate types of knowledge relevant to 
addiction work: the biological sciences; knowledge based on 
psychological theory; and the type of ‘sense-making’ which 
requires an ability to absorb another’s dilemmas, values and 
experience into one’s own frame of reference. Practical skills 
are improved through self-reflection on work practice and 
decisions. The successful practitioner, by looking beyond 
the phenomenon of a client’s dependency, has developed 
communication skills which can reveal traits, attitudes and 
needs and provide a fuller personal picture. 
Tacit skills and judgement complement research-based 
competencies and theoretical knowledge. These are 
important considerations for both educators and workplace 
managers. Effective education and training programmes 
not only impart skills but also facilitate the intellectual 
and personal development of the individual learner. These 
programmes increase the capacity of the practitioner to 
use their listening and observational abilities and to deal 
empathetically and skilfully with complex situations. It 
may not be possible to codify what is learned through 
this practice in the same way that clinical practice can be 
recorded and made available for analysis by others. But, as 
one researcher pointed out, we have techniques to manage 
and transfer this knowledge and, through research tools 
such as meta-ethnography, we have access to the evidence 
that others have provided. Practice should be informed by a 
pluralistic approach to the use of evidence which does not 
elevate a particular discipline but is nonetheless rigorous and 
soundly based in theory.
4. Structural change and systems focus
Responding to today’s substance use situation involves very 
different challenges to those of 2001, when the first National 
Drugs Strategy was published. New drugs require new 
approaches and polydrug use presents particular problems 
for services. Technological advances have transformed the 
manufacture, sale and distribution of both licit and illicit 
drugs. Alcohol is being integrated into a broader substance 
use strategy. Of equal significance will be a shift in drugs 
policy towards a recovery approach. It is not possible yet to 
envisage the full implications of this policy development. We 
can say that it will call for closer integration of services and 
will present new challenges as clients develop their personal 
pathways to complete and fulfilling lives.
These changes will have implications for workforce 
planning. In many respects Ireland is in a strong position 
to deal with these changes. A services manager described 
the many highly successful training programmes that are 
currently under way. Training, especially in treatment and 
Ms Marion Rackard, chair of Health Service Executive National 
Addiction Training Programme, speaking at the NDC 
conference (photo by JJ Berkeley)
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rehabilitation services, is being co-ordinated by teams 
comprising highly motivated managers, practitioners, 
community workers and health professionals. These 
partnerships can be strengthened and new links established 
between these teams and researchers and educators. The 
Scottish experience provides plentiful evidence of how these 
types of link can inform innovative and adaptable workforce 
development. The STRADA organisation, based in the 
University of Glasgow (www.projectstrada.org/ems/live), has 
used its knowledge of research, policy making and services 
to develop a comprehensive and coherent suite of addiction 
training programmes. In turn, policy, practice and research is 
informed by the work of STRADA. The STRADA experience is 
very relevant to the task of building an adaptable, skilled and 
motivated addiction workforce in Ireland.
We know from studies in other countries that the successful 
integration of new knowledge into work practice must 
be part of a systemic approach to dealing with workplace 
issues. There will need to be a comprehensive analysis of 
the addiction workforce in Ireland. This analysis would 
place individual learning alongside recruitment, planning, 
worker well-being, management and leadership and other 
organisational and structural considerations. This will 
be a formidable task but progress in this sector requires 
a commitment to an integrated approach to workforce 
development. From the evidence of this conference, there is 
a willingness to work together to ensure that education and 
learning transfer are central to this development.
We are grateful to all the speakers for their contribution to 
the day:
Prof Catherine Comiskey, Trinity College Dublin, chair of 
the National Advisory Committee on Drugs and Alcohol 
(Opening address)
Prof Shane Butler, Trinity College Dublin 
Mr Martin Keane, Health Research Board
Dr Patricia Mannix McNamara, University of Limerick
Prof John Wells; Dr Marie Claire Van Hout, Waterford 
Institute of Technology
Dr Derek Barter, National University of Ireland, Maynooth
Dr Ted Fleming (formerly of NUI Maynooth)
Ms Joy Barlow, strategic advisor, Scottish Training on Drugs 
and Alcohol (STRADA)
Ms Marion Rackard, chair of Health Service Executive 
National Addiction Training Programme
(Brian Galvin)
1. The conference was titled Putting knowledge to work through 
education: substance use workforce development in Ireland. 
It was held in Dublin on 18 April 2013. The conference 
presentations are available in video and pdf format at  
www.drugsandalcohol.ie/19737/ and  
www.drugsandalcohol.ie/19723/
Launch of Galway City alcohol strategy
Galway City strategy to prevent and reduce alcohol-related 
harm 2013–2017 was launched on 18 February by Mr Alex 
White TD, Minister of State for Primary Care. The five-year 
strategy seeks to prevent and reduce alcohol-related harm 
in Galway City and was prepared by Galway Healthy Cities 
Alcohol Forum in partnership with a range of organisations 
and groups. These include HSE West, An Garda Síochána, 
Western Region Drugs Task Force, City of Galway VEC, NUI 
Galway, Galway Mayo Institute of Technology, Galway City 
Council and Galway City Community Forum. 
The strategy is informed by research on effective approaches 
to preventing and reducing alcohol-related harm and 
focuses on four key areas: 
1. Prevention – the aim is to communicate and engage 
with policy makers, stakeholders and the general public. 
2. Supply, access and availability – the aim is to ensure 
that key factors influencing alcohol supply such as price, 
availability and marketing are regulated and controlled.
3. Screening, treatment and support services – the aim is to 
provide a range of services and supports. 
4. Research, monitoring and evaluation – the aim is to use 
information and research in decision making. 
It is anticipated that the outcomes of implementing the 
strategy will include:
 ■ Improved health, wellbeing and quality of life of people 
living in Galway City;
 ■ Reduced harmful use of alcohol;
 ■ Reduced alcohol-related harm;
 ■ Reduced incidents of alcohol-related crime and anti-
social behaviour;
 ■ Increased access 
to support 
services for those 
affected by 
another’s alcohol 
consumption;
 ■ Increased access to 
alcohol treatment 
services;
 ■ Reduced 
prevalence 
of alcohol at 
community 
events/activities; 
and
 ■ Reduced alcohol 
marketing in local 
areas. 
The Galway City Alcohol Forum will develop a yearly action 
plan to achieve the outcomes of the strategy and an update 
on progress made will be completed each year. This progress 
update will enable the Forum to adapt the action plan to 
reflect developments and changes in the local or national 
context. This will also ensure energy and momentum for the 
implementation of this strategy.
A copy of the strategy and the 2013 action plan may be 
accessed at www.drugsandalcohol.ie/19344. 
(Deirdre Mongan)
Addiction services workforce (continued)
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Government policy on homelessness 
On the 21 February 
2013, Ms Jan 
O’Sullivan TD, Minister 
for Housing and 
Planning, launched a 
policy statement on 
homelessness.1 In her 
speech, the minister 
restated her personal 
commitment to 
tackling homelessness 
as a priority. She also 
acknowledged that 
‘homelessness is not 
a label or category; 
it is a destructive 
social condition that 
can wreak havoc 
on human dignity and well-being. As a social condition it 
requires a social response – from Government, from the 
voluntary sector, from citizens’.2 
The policy statement follows a review of government 
policy towards homelessness which was undertaken by 
Eoin O’Sullivan in 2012.3 O’Sullivan is critical of the value 
for money obtained from state expenditure on tackling 
homelessness. He argues that ‘it is now clear that the 
historically high levels of statutory funding for homelessness 
services are not delivering satisfactory outcomes for 
homeless households…’ (p.24). This funding has traditionally 
being channelled into the provision of emergency-type 
shelter or resource-intensive interventions with various 
forms of ancillary support to prepare individuals to become 
‘housing ready’. In the case of individuals with alcohol and 
drug problems, this has meant that evidence of abstinence 
or sustained stabilisation was often required prior to their 
being considered for more sustainable accommodation. 
O’Sullivan reviewed a number of studies that reported 
outcomes from both the broad church of the housing-
ready / treatment-first approach and the housing-first (or 
housing-led) approach. The latter does not require people 
to demonstrate abstinence or provide evidence that they 
are ready to be housed. The housing-led approach seeks to 
place homeless people in sustainable rented accommodation 
first, and provides ‘floating supports’ at the request of the 
person being housed. Such supports may include assistance 
with social welfare enquiries, developing independent living 
skills or seeking help for addiction problems. O’Sullivan 
concludes that ‘the overwhelming evidence points to the 
effectiveness of a Housing Led approach rather than one that 
seeks to promote Treatment First’ (p.35). 
The policy statement on homelessness endorses this view 
of the evidence base and declares that the policy’s primary 
purpose is to make explicit the government’s commitment 
to ending homelessness by implementing the housing-led 
approach. The policy statement asserts the government’s 
aim to end long-term homelessness by the end of 2016 and 
encapsulates the government’s response to homelessness to 
include the following components: 
1. Preventing homelessness
2. Eliminating the need to sleep rough
3. Eliminating long-term occupation of emergency 
accommodation
4. Providing long-term housing solutions
5. Ensuring effective services
6. Better co-ordinated funding arrangements.
At the launch, the Minister announced that an oversight 
group has been established to monitor and review the 
housing-led approach being advocated in the policy 
statement. To assist the group in monitoring the measures 
and approach outlined in the policy, the minister announced 
a set of seven indicators that will be used to ‘demonstrate 
the dynamics’ of homelessness as it is addressed: 
1. Number of new homeless presentations on a daily basis
2. Number of persons in emergency accommodation for 
longer than six months
3. Number of persons leaving emergency accommodation
4. Occupancy rate in emergency accommodation
5. Number of persons moving on into independent living 
with support
6. Number of persons moving on into independent living 
without support
7. Number of persons sleeping rough voluntarily and 
involuntarily
The publication of this policy statement is a welcome 
development and makes explicit the government’s 
commitment to implement the housing-led approach, a 
model grounded in consistent evidence on efficiency and 
effectiveness. However, if the model is to be applied and 
the government’s target of ending long-term homelessness 
by 2016 is to be realised, then sufficient numbers of 
housing units must be made available. In the current 
climate of austerity and fiscal restraints, these outputs may 
be compromised. Indeed, a recent article by Mary Regan, 
political correspondent for the Irish Examiner, reports Minster 
O’Sullivan’s acknowledgement that ‘her department is 
“struggling” with ensuring it has enough accommodation to 
meet demand. [But]…her department hopes to secure 3,000 
units from Nama’.4 
(Martin Keane)
1. Department of the Environment, Community and Local 
Government (2013) Homelessness policy statement. Dublin: 
Department of the Environment, Community and Local 
Government. www.drugsandalcohol.ie/19346
2. O’Sullivan J (2013, 21 February) Speech by Ms Jan 
O’Sullivan TD, Minister for Housing and Planning on the 
launch of the homeless policy statement. Available at  
www.drugsandalcohol.ie/19346
3. O’Sullivan E (2012) Ending homelessness: a housing-
led approach. Dublin: Department of the Environment, 
Community and Local Government. www.environ.ie/
en/Publications/DevelopmentandHousing/Housing/
FileDownLoad,32437,en.pdf
4. Regan M (2013, 22 February) ‘Hope is not enough’ to end 
long-term homelessness. Irish Examiner. Accessed 8 May 
2013 at www.irishexaminer.com/ireland/hope-not-enough-
to-end-long-term-homelessness-223411.html
drugnet 
Ireland
20
Legal proceedings for drug offences  
2004–2011
This article looks at trends in legal proceedings for drug 
offences in the years 2004–2011. It should be noted 
that drug offence data are primarily a reflection of law 
enforcement activity. Consequently, they are affected in any 
given period by such factors as law enforcement resources, 
strategies and priorities, and by the vulnerability of drug 
users and drug traffickers to law enforcement activities. 
Having said that, when compared with other data sources 
such as drug treatment for example, they can provide a 
useful indicator of overall drug trends. Alternatively, where 
law enforcement trends differ from those of other data 
sources in a given period they may reveal something about 
specific law enforcement strategies or activities at that time, 
something that can be further investigated through research.
Figures 1 and 2 show trends in proceedings for drug 
offences from 2004 to 2011. As can be seen from Figure 
1, the number of legal proceedings for the possession of 
drugs for personal use (simple possession) decreased in 
2009 for the first time since 2004. The number continued 
to fall in the following two years. Simple possession offences 
accounted for almost 69% of total drug offence proceedings 
in 2011. Proceedings for drug supply have also decreased 
marginally since 2009.
Obstruction offences often involve an alleged offender 
resisting a drug search or an arrest or attempting to dispose 
of drugs to evade detection. Such offences continue to 
account for the largest number of prosecutions, although 
numbers declined from a high of 415 in 2007 to 245 in 
2011, approaching the 2004 figure of 242. Proceedings 
for the offence of forged/altered prescriptions have also 
remained fairly constant since 2004. Another noteworthy 
development has been the continued increase in the offence 
of cultivating/manufacturing controlled drugs. Proceedings 
for this offence have continued to increase since 2005, when 
there were 29 related proceedings, reaching 167 in 2009 
and then more than doubling to 355 in 2011. It is unclear 
whether this increase reflects a genuine growth in the 
commission of such offences or a sustained concentration 
of law enforcement on their detection. For example, in 
2010, the Garda Síochána conducted Operation Nitrogen, 
a nationwide investigation into cannabis cultivation sites 
by district and divisional drug units.2 Although the specific 
focus of this operation may have had an impact on the 
data presented here, a recent report jointly published 
by the EMCDDA and Europol highlighted the increased 
involvement of organised crime groups in cannabis 
cultivation in many European countries, including Ireland.3
Drug driving offences
Figure 3 shows the trend in prosecutions for driving or being 
in charge of a vehicle while under the influence of drugs 
(DUID) between 2004 and 2011. Between 2006 and 2009 
the number of prosecutions for DUID increased from 74 to 
703, an increase of 850%. It is unclear why this increase 
occurred. It could be due to an increase in the incidence 
of DUID or, the more likely possibility, to an increase in 
targeted police activity in this area. Since 2009, the number 
of such offences has decreased significantly, with 337 
reported prosecutions in 2011.
Figure 2 Trends in relevant legal proceedings for 
selected drug offences, 2004–2011
Source: Central Statistics Office (2013) Interactive  
tables online1
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Figure 3 Trend in relevant legal proceedings for 
driving in charge of a vehicle while under 
the influence of drugs, 2004–2011
Source: Central Statistics Office (2013) Interactive  
tables online1
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Figure 1 Trends in relevant legal proceedings for 
total drug offences, and for possession for 
personal use and for supply, 2004–2011
Source: Central Statistics Office (2013) Interactive  
tables online1
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Drug offence data can assist us in understanding aspects of 
the operation of the illicit drug market in Ireland. Data on 
drug offence prosecutions by Garda division are a possible 
indicator of national drug distribution patterns. While these 
data primarily reflect law enforcement activities and the 
relative ease of detection of different drugs, when compared 
with other sources, such as drug treatment data, for 
example, they can show us trends in market developments 
throughout the State. Such data can also indicate trafficking 
patterns by showing whether there is a concentration of 
prosecutions along specific routes. Figures 4 and 5 show 
trends in relevant legal proceedings for possession of drugs 
by Garda region. It should be noted that possession offences 
include both possession for personal use and possession 
for the purpose of supply. It is not possible to distinguish 
between these two offences in the data reported by Garda 
region. However, in the country as a whole, possession for 
personal use accounted for between 65% and 75% of all 
possession cases in the years 2004–2011 (Figure 1).
As shown in Figure 4, an upward trend since 2004 in 
relevant legal proceedings for possession (for personal use 
and for supply) continued until 2008, and then decreased 
between 2008 and 2011. The majority of such proceedings 
were in the Dublin Metropolitan Region (DMR), where the 
number increased steadily from 1,515 in 2004 to 5,270 in 
2008. The number has fallen since then, with 3,773 such 
offences prosecuted in 2011, below the figure of 4,077 
reported for 2007.
Figure 5 shows trends in supply offences by Garda region, 
excluding Dublin. Numbers have increased in all regions 
since 2004. This reflects the reality that drug markets are no 
longer primarily a Dublin-based phenomenon. Following 
this general increase throughout the country since 2004, the 
number of relevant legal proceedings for drug possession 
(for personal use and for supply) decreased in all regions 
between 2008 and 2011, with the exception of the 
Northern Region where the figure fluctuated slightly in that 
period.
(Johnny Connolly)
1. Central Statistics Office (2013) Interactive tables online. 
Table CJA02: Offences by type of offence, year and statistic. 
www.cso.ie/px/pxeirestat/Statire/SelectVarVal/Define.
asp?maintable=CJA02&PLanguage=0
2. An Garda Síochána (2012) Annual report 2011. Dublin:  
An Garda Síochána. www.drugsandalcohol.ie/17953
3. European Monitoring Centre for Drugs and Drug Addiction, 
Europol (2013) EU drug markets report: a strategic analysis. 
Luxembourg: Publications Office of the European Union. 
www.drugsandalcohol.ie/19227
4. Central Statistics Office (2013) Garda recorded crime 
satistics 2003–2011. Excel tables online, Table 4 complete. 
www.cso.ie/en/releasesandpublications/crimeandjustice/
gardarecordedcrimestatistics2003–2011exceltables/
Figure 4 Trends in relevant legal proceedings for 
possession of drugs for personal use and for 
sale or supply, nationally and in the Dublin 
Metropolitan Region, 2004–2011
Source: Central Statistics Office (2013) Excel tables online4
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Figure 5 Trends in relevant legal proceedings for 
possession of drugs for personal use and 
for sale or supply, by region, excluding the 
DMR, 2004–2011
Source: Central Statistics Office (2013) Excel tables online4
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Drug offences 2004–2011 (continued)
INCB annual report 2012
The International Narcotics Control Board (INCB) is 
responsible for overseeing the operation of the international 
drug treaties, management of markets in medicines 
controlled by the treaties, and ensuring the supply of 
opioids for pain and other medical uses.1 The Board, 
which comprises 13 experts elected by the United Nations 
Economic and Social Council, deems itself the guardian 
of the treaties and is often critical of countries it judges 
as having violated their provisions. For example, in its 
annual report for 2012,2 Denmark comes in for criticism for 
proposals to establish drug consumption rooms, and ‘coffee 
shops’ in the Netherlands are considered by the Board to 
be in violation of the international drug control conventions 
(pp.99–100). The report highlights the publication of the 
National Substance Misuse Strategy in Ireland. It also refers 
to the ‘heroin drought’ identified in Ireland in late 2010 
and relates this to a decrease in heroin being trafficked to 
the United Kingdom via Turkey (p.103). Another interesting 
drug market feature noted in the report relates to the 
trafficking of amphetamine-type stimulants (ATS) into 
Australia. Ireland, along with Canada, China (including Hong 
Kong) and India are the main embarkation points for those 
detected bringing ATS into Australia (p.112). 
(Johnny Connolly)
1. For a recent article on the international drug conventions, 
see Room R and Reuter P (2012) How well do international 
drug conventions protect public health? The Lancet, 
379(9810): 84–91.
2. International Narcotics Control Board (2013) Report of the 
International Narcotics Control Board for 2012. Vienna: United 
Nations Office. Available at www.drugsandalcohol.ie/19428
drugnet 
Ireland
22
Recent publications
Books
Books recently acquired by the National Documentation Centre 
on Drug Use.
Drugs 2.0: the web revolution 
that’s changing how the world 
gets high
by Mike Power
Portobello Books (2013)
ISBN: 9781–1–84627–459–6
Journal articles
The following abstracts are cited from recently published journal 
articles relating to the drugs situation in Ireland.
Cannabis misinterpretation and misadventure in a 
coroner’s court
Tormey WP 
Medicine, science, and the law, 2012, 52(4): 229–230.
www.drugsandalcohol.ie/19527
A 37-year-old, one-pack-per-day tobacco smoker collapsed 
and died at home. At autopsy, he had an occluded left anterior 
descending coronary artery. Δ(9)-Tetrahydrocannabinol-
carboxylic acid was found in his urine but no cannabinoids were 
detected in his blood. Misadventure was the inquest verdict 
on the basis of the urinary cannabis, with acute myocardial 
infarction as the primary cause and cannabis as the secondary 
cause of death. Such a conclusion is a misinterpretation of the 
evidence when the time duration for cannabis as a trigger for 
myocardial infarction is at most two hours. The absence of 
cannabis in the blood likely places the time since inhalation at 
more than two hours. The role of tobacco smoking as a trigger 
was ignored. Cotinine, the biochemical marker of tobacco 
smoke, should be added to the standard toxicological screen 
in the guidelines on autopsy practice of the Royal College of 
Pathologists.
The epidemiology of assault-related hospital in-patient 
admissions and ED attendances 
O’Farrell A, de la Harpe D and Geary U 
Irish Medical Journal, 2013, 106(3).
www.drugsandalcohol.ie/19503
The aim of this study was to describe the epidemiology and 
impact of serious assault warranting in-patient care over six 
years and its impact on ED attendances in a large teaching 
hospital in Dublin over 2 years. There were 16,079 emergency 
assault-related in-patient hospital discharges reducing from 
60.1 per 100,000 population in 2005 to 50.6 per 100,000 
population in 2010. The median length of stay was 1 day 
(1–466) representing 49,870 bed days. The majority were young 
males (13,921, 86.6%; median age 26 years). Overall crime 
figures showed a similar reduction. However, knife crimes did 
not reduce over this period. Data on ED attendances confirmed 
the age and gender profile and also showed an increase at 
weekends. Alcohol misuse was recorded in 2,292/16079 (14%) 
of in-patient cases and 242/2484 (10%) in ED attendances. An 
inter-sectoral preventative approach specifically targeting knife 
crime is required to reduce this burden on health services.
Silk Road, the virtual drug marketplace: a single case 
study of user experiences
Van Hout MC and Bingham T 
International Journal of Drug Policy, 2013, 1 March, Early online.
www.drugsandalcohol.ie/19490
Background: The online promotion of ‘drug shopping’ and 
user information networks is of increasing public health and law 
enforcement concern. An online drug marketplace called ‘Silk 
Road’ has been operating on the ‘Deep Web’ since February 
2011 and was designed to revolutionise contemporary drug 
consumerism. 
Methods: A single case study approach explored a ‘Silk Road’ 
user’s motives for online drug purchasing, experiences of 
accessing and using the website, drug information sourcing, 
decision making and purchasing, outcomes and settings for use, 
and perspectives around security. The participant was recruited 
following a lengthy relationship building phase on the ‘Silk 
Road’ chat forum. 
Results: The male participant described his motives, experiences 
of purchasing processes and drugs used from ‘Silk Road’. 
Consumer experiences on ‘Silk Road’ were described as 
‘euphoric’ due to the wide choice of drugs available, relatively 
easy once navigating the Tor Browser (encryption software) and 
using ‘Bitcoins’ for transactions, and perceived as safer than 
negotiating illicit drug markets. Online researching of drug 
outcomes, particularly for new psychoactive substances was 
reported. Relationships between vendors and consumers were 
described as based on cyber levels of trust and professionalism, 
and supported by ‘stealth modes’, user feedback and resolution 
modes. The reality of his drug use was described as covert and 
solitary with psychonautic characteristics, which contrasted with 
his membership, participation and feelings of safety within the 
‘Silk Road’ community. 
Conclusion: ‘Silk Road’ as online drug marketplace presents 
an interesting displacement away from ‘traditional’ online 
and street sources of drug supply. Member support and harm 
reduction ethos within this virtual community maximises 
consumer decision-making and positive drug experiences, and 
minimises potential harms and consumer perceived risks. Future 
research is necessary to explore experiences and backgrounds of 
other users.
Effectiveness of motivational interviewing in influencing 
smoking cessation in pregnant and postpartum 
disadvantaged women
Hayes C, Collins C, O’Carroll H, Wyse E, Gunning M, Geary M 
and Kelleher CC 
Nicotine & Tobacco Research, 2013, 15(5): 969–977.
www.drugsandalcohol.ie/19420
Introduction: Systematic assessments of Motivational 
Interviewing (MI) in smoking behavior have been rare to date. 
This study aimed to determine whether an integrated approach, 
involving staff training in MI techniques, was sufficient to affect 
change in smoking status or intensity in low-income pregnant 
and postpartum women. 
Methods: Overall, 500 consecutive smokers were recruited 
at first prenatal visit to public antenatal clinics. Following staff 
training, 500 more were recruited (intervention group). Data 
were recorded at 28–32 weeks gestation, after birth, at 3–4 and 
7–9 months postpartum. The primary outcome measure was 
self-reported continued abstinence from smoking verified by 
urinary cotinine analysis. Changes in smoking intensity were  
also measured. 
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Results: There was no significant difference in the proportion of 
smokers in the intervention and control groups who reported 
stopping smoking at 28–32 weeks gestation (8.2% vs. 8.8%; 
p = .73), 1 week after birth (8.6% vs. 11.4%; p = .14), 3–4 
months after birth (5.8% vs. 4.8%; p = .48), or 7–9 months 
after birth (5.2% vs. 4.0%; p = .36). Although more cases were 
nonsmoking at the second visit, 14.8% [95% CI = 11.8–18.5] vs. 
13.1% controls [95% CI = 10.3–16.6], this was not statistically 
significant. 
Conclusions: MI delivered at a number of time points during 
pregnancy and up to 9 months postpartum failed to affect 
quit rates. It may have had a small effect in preventing relapse 
among spontaneous quitters in late pregnancy though the 
validity of this remains uncertain. 
Attitudes of women from five European countries 
regarding tobacco control policies
Dresler CM, Wei M, Heck JE, Allwright S, Haglund M, Sanchez S 
et al. 
Scandinavian Journal of Public Health, 2013, 41(2): 126–133.
www.drugsandalcohol.ie/19419
Aims: Tobacco-related cancers and, in particular, lung cancer 
still represent a substantial public health epidemic across Europe 
as a result of high rates of smoking prevalence. Countries in 
Europe have proposed and implemented tobacco control 
policies to reduce smoking prevalence, with some countries 
being more progressive than others. The aim of this study was 
to examine factors that influenced women’s attitudes in five 
European countries relative to comprehensive smoke-free laws in 
those countries.
Methods: A cross-sectional landline telephone survey on 
attitudes towards tobacco control laws was conducted in France, 
Ireland, Italy, the Czech Republic and Sweden. Attitudinal scores 
were determined for each respondent relative to questions 
about smoke-free laws. Logistic regression models were used to 
obtain odds ratios with 95% confidence intervals. 
Results: A total of 5,000 women were interviewed (1,000 
women from each country). The majority, regardless of smoking 
history, objected to smoking in public buses, enclosed shopping 
centers, hospitals, and other indoor work places. More women 
who had quit smoking believed that new tobacco control laws 
would prompt cessation, compared with women who still 
smoked.
Conclusions: In general, there is very high support for national 
smoke-free laws that cover bars, restaurants, and public 
transport systems. As such laws are implemented, attitudes 
do change, as demonstrated by the differences between 
countries such as Ireland and the Czech Republic. Implementing 
comprehensive smoke-free laws will gain high approval and will 
be associated with prompting people to quit.
Reductions in cardiovascular, cerebrovascular, and 
respiratory mortality following the national Irish smoking 
ban: interrupted time-series analysis 
Stallings-Smith S, Zeka A, Goodman P, Kabir Z and Clancy L 
PLoS ONE, 2013, 8(4). 
www.drugsandalcohol.ie/19756
Background: Previous studies have shown decreases in 
cardiovascular mortality following the implementation of 
comprehensive smoking bans. It is not known whether 
cerebrovascular or respiratory mortality decreases post ban. On 
29 March 2004, the Republic of Ireland became the first country 
in the world to implement a national workplace smoking ban. 
The aim of this study was to assess the effect of this policy on 
all-cause and cause-specific, non-trauma mortality.
Methods: A time-series epidemiologic assessment was 
conducted, utilizing Poisson regression to examine weekly age 
and gender-standardized rates for 215,878 non-trauma deaths 
in the Irish population aged 35 years and over. The study period 
was from 1January 2000 to 31 December 2007, with a post-ban 
follow-up of 3.75 years. All models were adjusted for time trend, 
season, influenza, and smoking prevalence.
Results: Following ban implementation, an immediate 13% 
decrease in all-cause mortality (RR: 0.87; 95% CI: 0.76 0.99), 
a 26% reduction in ischemic heart disease (IHD) (RR: 0.74; 
95% CI: 0.63–0.88), a 32% reduction in stroke (RR: 0.68; 95% 
CI: 0.54– 0.85), and a 38% reduction in chronic obstructive 
pulmonary disease (COPD) (RR: 0.62; 95% CI: 0.46–0.83) 
mortality was observed. Post-ban reductions in IHD, stroke, and 
COPD mortalities were seen in ages 65 years and over, but not 
in ages 35–64 years. COPD mortality reductions were found 
only in females (RR: 0.47; 95% CI: 0.32–0.70). Post-ban annual 
trend reductions were not detected for any smoking-related 
causes of death. Unadjusted estimates indicate that 3,726 (95% 
CI: 2,305 4,629) smoking-related deaths were likely prevented 
post-ban. Mortality decreases were primarily due to reductions 
in passive smoking.
Conclusions: The national Irish smoking ban was associated 
with immediate reductions in early mortality. Importantly, 
postban risk differences did not change with a longer follow-
up period. This study corroborates previous evidence for 
cardiovascular causes, and is the first to demonstrate reductions 
in cerebrovascular and respiratory causes.
A comparative analysis of health policy performance in 
43 European countries 
Mackenbach JP and McKee M 
Journal of Public Health, 2013, 23(2): 195–344. 
www.drugsandalcohol.ie/19744
Background: It is unknown whether European countries differ 
systematically in their pursuit of health policies, and what 
the determinants of these differences are. In this article, we 
assess the extent to which European countries vary in the 
implementation of health policies in 10 different areas, and 
we exploit these variations to investigate the role of political, 
economic and social determinants of health policy. Data 
and Methods: We reviewed policies in the field of tobacco; 
alcohol; food and nutrition; fertility, pregnancy and childbirth; 
child health; infectious diseases; hypertension detection and 
treatment; cancer screening; road safety and air pollution. We 
developed a set of 27 ‘process’ and ‘outcome’ indicators, as 
well as a summary score indicating a country’s overall success in 
implementing effective health policies. In exploratory regression 
analyses, we related these indicators to six background factors: 
national income, survival/self expression values, democracy, 
government effectiveness, left-party participation in government 
and ethnic fractionalization. 
Results: We found striking variations between European 
countries in process and outcome indicators of health policies. 
On the whole, Sweden, Norway and Iceland perform best, and 
Ukraine, Russian Federation and Armenia perform worst. Within 
Western Europe, some countries, such as Denmark and Belgium, 
perform significantly worse than their neighbours. Survival/
self-expression values and ethnic fractionalization were the main 
predictors of the health policy performance summary score. 
National income, survival/self-expression values and government 
effectiveness were the main predictors of countries’ performance 
in specific areas of health policy.
Conclusions: Although many new preventive interventions have 
been developed, their implementation appears to have varied 
enormously among European countries. Substantial health gains 
can be achieved if all countries would follow best practice, but 
this probably requires the removal of barriers related to both the 
‘will’ and the ‘means’ to implement health policies.
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Upcoming events
(Compiled by Joan Moore – jmoore@hrb.ie) 
August
21–23 August 2013
Contemporary Drug Problems Conference
Complexity: Researching alcohol and other drugs in a multiple 
world
Venue: Aarhus University, Denmark 
Organised by / Contact: Aarhus University Conference organisers
Email: CDP@curtin.edu.au
Web: psy.au.dk/en/research/research-centres-and-units/centre-for-
alcohol-and-drug-research/research/conferences/contemporary-drug-
problems/ 
Information: An interdisciplinary conference for international 
researchers in drug use and addiction studies from a range of research 
disciplines. This conference offers a forum in which the issues and 
dilemmas of complexity in alcohol and other drug research can be 
explored. It welcomes research based on quantitative and qualitative 
methods, and encourages innovative use of methods, concepts and 
theoretical approaches. Following the conference, Contemporary Drug 
Problems, an interdisciplinary quarterly and one of the driving forces 
behind the conference, will publish a special issue featuring selected 
papers from the conference. 
September
17–20 September 2013
Rehabilitation and Drug Policy  
14th EFTC Conference 
Venue: Prague, Czech Republic
Organised by / Contact: European Federation of Therapeutic 
Communities (EFTC)
Email: eftc@conference.cz
Web: www.conference.cz/EFTC2013/index.htm
Information: This Conference will be hosted by Magdalena, a non-
governmental organisation, and the Clinic of Addictology at Charles 
University. Its purpose is to discuss the pressing issues we all face in this 
changing world of addiction: development trends in the therapeutic 
community; research and education; and special populations and 
approaches. This topic not only invites us to reflect upon the basic 
and classical therapeutic ideas from a contemporary perspective, but 
also to discuss their current transformation, modification, and new 
developments.
18 September 2013
The EU Drugs Strategy 2013–2020: Combating Illicit Trafficking 
and Substance Misusee 
Venue: The Silken Berlaymont Hotel, Brussels
Organised by / Contact: Public Policy Exchange
Email: parvin.madahar@publicpolicyexchange.co.uk
Tel: +44 (0) 20 3137 8630
Web: www.publicpolicyexchange.co.uk
Information: This special International Symposium provides a 
timely opportunity for practitioners and stakeholders across Europe 
to discuss the latest challenges and consider the next steps needed 
to win the fight against illicit drug trafficking and substance misuse 
through holistic, multi-level and cross-border approaches. Public Policy 
Exchange welcomes the participation of all key partners, responsible 
authorities and stakeholders. 
21 September 2013
2nd Annual Recovery Walk
Venue: Civic Offices, Wood Quay, Dublin 
Organised by / Contact: The Recovery Foundation
Email: info@recoverywalkireland.com
Web: www.recoverywalkireland.com 
Information: Addiction is a community-wide problem – recovery 
should be a community-wide celebration. The recovery walk is a free, 
fun-filled, family event with food and music. Register on our website.
October
31 October 2013
Digital Alcohol Marketing – Online Conference
Organised by / Contact: European Centre for Monitoring Alcohol 
Marketing (EUCAM)
Email: eucam@eucam.info
Web: www.eucam.info
Information: Developments in digital alcohol marketing have gone 
rapidly as alcohol marketers adapt to keep up with the latest trends and 
technologies. Consequently, there is a need for up-to-date evidence 
based policy measures. To ring the alarm bell, close the gap in the 
literature and publicize much needed policy recommendations, EUCAM 
is dedicating its first online conference on the subject of digital alcohol 
marketing. The conference will result in the publication of the EUCAM 
Manifesto on Digital Alcohol Marketing. NGOs, policy officials and 
scientists are welcome to participate.
November
6 November 2013
Game on: drug and alcohol services and the new local players
Venue: Connaught Rooms, Great Queen Street, London WC2B 5DA
Organised by / Contact: DrugScope 
Email: conferences@drugscope.org.uk
Web: www.drugscope.org.uk/events
Information: It has been a long time coming, but now it is here. As the 
National Treatment Agency rides off into the sunset, over the hill comes 
Public Health England and with it a whole new landscape in which drug 
and alcohol services need to operate. PHE will be much more ‘hands 
off’ than the NTA and for some that will be welcome. But it does mean 
that the voice for services inside Whitehall will be quieter – and we will 
all need to get smarter at making the case for services at the local level. 
So we have speakers who reflect the new dynamic as well as those 
reporting on developments in drug use which may well impact  
on services.
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